kumar - master cv 2016 feb

Nagi B. KumarFebruary 2016

Curriculum Vitae for: Nagi B. Kumar, Ph.D., R.D., FADADate: February 2016

Current Position Senior Member (Tenured)Director, Cancer ChemopreventionDepartment of Cancer EpidemiologyPopulation Sciences DivisionH. Lee Moffitt Cancer Center and Research Institute, Inc.12902 Magnolia Drive, MRC/CANCONTTampa, FL 33612-9497

Telephone: (813) 745-6885Fax: (813) 745-7183Email: [email protected]

ProfessorDepartment of Oncologic Sciences, MDC 44College of MedicineUniversity of South Florida12901 Bruce B. Downs BoulevardTampa, FL 33612-4742

Education1976 B.S., Nutrition and Dietetics, Madras University, Madras, India1985 M.A., Adult Education, University of South Florida, Tampa, FL1992 Ph.D., Interdisciplinary Studies, Applied Behavior Analysis and Public Health

Nutrition, University of South Florida, Tampa, FL

Postgraduate Training and Fellowship1980 Academic Requirements for Registration, American Dietetic Association, Queen’s

College, City University of New York (CUNY), New York, NY1981 Dietetic Internship Program, City Hospital Center at Elmhurst, Mt. Sinai School of Medicine, New York, NY1995 National Cancer Institute: Fundamentals of Grant Writing for Cancer Control

Science1998 Fellow, American Dietetic Association2006 Accelerating Anticancer Agent Development and Validation Workshop, Bethesda,

MD. National Institute of Health (NIH)/National Cancer Institute (NCI)/ American Society of Clinical Oncology (ASCO) / (American Institute for Cancer Research (AICR) /Federal Drug Administration (FDA) NIH-NCI /ASCO/ AICR/ FDA and Duke Comprehensive Cancer Center.

Academic Appointments and Employment1978 – 1982 Clinical Dietitian, City Hospital Center at Elmhurst, Mt. Sinai School of Medicine,

New York, NY

of 59

mailto:[email protected]


1982 – 1986 Director of Dietary Services and Chief Clinical Dietitian, Centro Asturiano Hospital, Inc., Tampa, FL1984 – 1986 Consultant Dietitian, Foster Medical Home Health Care, Pinellas Park, FL1985 – 1987 Consultant Dietitian, Alcohol Community Treatment Services, Inc., Tampa, FL1986 – 1987 Clinical Dietitian, Department of Nutrition, H. Lee Moffitt Cancer Center and

Research Institute, Inc., Tampa, FL1986 – 1991 Consultant Dietitian, Centro Asturiano Hospital, Inc., Tampa, FL1987 – 1992 Research Dietitian/Research Associate, Cancer Prevention Program, Department

of Medical Oncology, H. Lee Moffitt Cancer Center and Research Institute, Inc. Tampa, FL

1992 – 2000 Assistant Professor (Courtesy Appointment), Department of Community and Family Health, University of South Florida, College of Public Health, Tampa, FL

1992 – 2006 Director, Department of Nutrition, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

1994 – 2001 Assistant Professor (Courtesy Appointment), Department of Community and Family Health, University of South Florida, College of Nursing, Health Sciences Center, Tampa, FL

2001 – 2002 Assistant Professor (Courtesy Appointment), Department of Community and Family Health, University of South Florida, College of Medicine, Tampa, FL

2001 – 2002 Assistant Professor (Courtesy Appointment), Department of Interdisciplinary Oncology, University of South Florida, College of Medicine, Tampa, FL

2002 – 2006 Associate Professor (Courtesy Appointment), Department of Interdisciplinary Oncology, University of South Florida, College of Medicine, Tampa, FL

2006 – 2008 Associate Professor, Health Outcomes and Behavior, Division of Cancer Control, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

2006 – 2011 Director, Nutrition Research, H. Lee Moffitt Cancer Center and Research

Institute, Inc., Tampa, FL2006 – 2008 Co-Leader, Integrative Medicine, H. Lee Moffitt Cancer Center and Research

Institute, Inc., Tampa, FL2008 – Senior Member, H. Lee Moffitt Cancer Center and Research Institute, Inc.,

Tampa, FL2008 – Professor, Department of Interdisciplinary Oncology, University of

South Florida, College of Medicine, Tampa, FL2011 – Director, Cancer Chemoprevention, H. Lee Moffitt Cancer Center and

Research Institute, Inc., Tampa, FL

Licenses

of 59


2007 – Dietitian/Nutritionist, ND 1627, Division of Medical Quality Assurance, State of

Florida

Board CertificationCommission on Dietetic Registration, R566113, Academy of Nutrition and DieteticsFellow of the Academy of Nutrition and Dietetics.

Languages SpokenEnglish, Tamil

Teaching Experience

1. University Courses1992 – 1997 University of South Florida, College of Nursing, Tampa, FL

Human Nutrition (HUN 2201)Class Size: 300

1994 – 1995 University of South Florida, College of Public Health, Tampa, FLGraduate Courses:

a. Nutritional Assessmentb. Diet and Diseasec. Biology of Nutrition in Health and Disease

University of South Florida, College of Public Health and Nursing, Tampa, FL

d. Public Health Nutrition in the Adult and Aging Population

2003 – University of South Florida, College of Medicine, Tampa, FLBMS6920.717M05Colloquium – Years I and IIProgram Co-Director, Nutrition Lecture Services (First and Second

Year Medical Students)

2009 – Clinical Trials Workshop, Course FacultyPh.D. Cancer Biology, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

2. Other Courses and National SymposiaMarch 1995 Anthropometry, Sex Hormones and Cancer Risk. 7th Annual

Meeting of the New England Association for Cancer Research, Brown University, Providence, RI

September 1995 Can Nutrients Inhibit the Cancer Process? Adjuvant Nutrition and Cancer Treatment. American College of Nutrition Cancer Treatment and Research Foundation

of 59


August 2005 The Promises and Perils of Lycopene/Tomato Supplementation and Cancer Prevention. NIH/NCI/NCCAM/ODS/FDA – Session IV: What Have We Learned from Clinical Trials?

October 2006 Disease-Specific Nutritional Approaches in Hypothalamic Pituitary Disorders. 4th National Symposium on Pituitary Disorders

November 2006 Metabolic Health: Nutritional Factors, Special Diets, Calorie Restriction and Aging. 2nd International Society for Applied Research in Aging (SARA) - Symposium on Clinical Interventions in Aging

July 2009 National Cancer Institute. Botanicals and Cancer Research: Clinical Trials Workshop

3. Teaching and Training Experience

Undergraduate Training2004 – Faculty Mentor, Project LINK

Project LINK (Leaders In New Knowledge), is a program that establishes research experiences for under- represented high school/undergraduate students, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

2004 – Faculty Mentor, SPARK (H. Lee Moffitt Cancer Center and Research Institute, Inc. Summer Internship Program)The goal of SPARK is to provide an authentic educational experience for students who have an aptitude for science and high level of interest in pursuing a career in research and direct them toward a future in Cancer Research. H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

2006 – 2009 Principle Investigator/Program Directors HBCU Undergraduate Collaborative Summer Training Program to

Inspire Students in Prostate Cancer Research.The major goals of the project are to inspire and increase the number of FAMU undergraduate students in cancer research by providing meaningful didactic and research experience and training in basic, biomedical, clinical and/or population sciences research in prostate cancer. (12 minority undergraduates trained in this program with 9/12 completed doctoral programs and 2 graduate programs.)

Guest Lecturer2006 University of South Florida, College of Public Health, Tampa, FL

Nutrition and CancerCourse: Cancer EpidemiologyCourse Directors: Tom Mason, MPH

of 59


2006 University of South Florida, College of Public Health and College of Medicine, Tampa, FLCultural Influences and Diversity Issues in Clinical Research Recruitment and Retention in Clinical Trials

2014 Research Issues in Cancer Control. University of South Florida, College of

Nursing, Tampa, FL Course Director: Hsiao-Lan Wang, PhD, RN, CMSRN, HFS), Tampa,

FL

Graduate Training1995 – 1997 Dietetic Internship Program, Pasco County Health Department, Pasco

County, FLNutrition Research

1997 – 2011 Dietetic Internship Program, Bay Pines VA Hospital, St. Petersburg, FL

Nutrition Research

Dietetic Internship Program, James A. Haley VA Hospital, Tampa, FL

Nutrition Research

2003 – 2012 University of South Florida, College of Medicine, Tampa, FLProject Co-DirectorNutrition Colloquium Lecture Series First Year Medical Students

2004 – University of South Florida, College of Nursing, Tampa, FLPathobiology of Neoplasia (Oncology Nursing Graduate Nursing

Students)Faculty Director: Susan McMillan, PhDCourse Directors: Meade, Fernandez, and Zuckerman

2008 – University of South Florida, College of Medicine, Pain Medicine Residency

Program Lecture Series, Tampa, FLNutritional Implications and Management of Cancer PainFaculty Director: Raphael Miguel, MD

2009 – Cancer Biology PhD Program, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FLClinical Trails WorkshopFaculty Director: Doug Cress, PhD

Post-Doctoral Training2004 – 2008 Co-Principle Investigator/Co-Project Director

Florida A & M University (FAMU) Center for Minority Prostate Cancer Training and Research: A Collaborative Program between FAMU and

of 59


the H. Lee Moffitt Cancer Center and Research Institute, Inc. (MCC). HBCU Collaborative Partnership trainingThe major goals of the project are to reduce the disproportionate burden of prostate cancer incidence and mortality among African American men by (i) increasing the number of FAMU scientists focusing on prostate cancer research, and (ii) enhancing the capacity for scientific research in prostate cancer at FAMU.

January – August 2010Meghan Borysova, PhD Racial and Ethnic Disparities in Prostate Cancer: Studies in an Incarcerated CommunityCenter for Equal Health, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (MCC), University of South Florida, Tampa, FL (USF)

January 2010 –Ganna Chornokur, PhDComprehensive Population-Specific Marker Panel for Early Prostate Cancer Diagnostics and Risk Assessment: The DETECT StudyDepartment of Defense (DOD) Health Disparity Training Grant

August 2010 – December 2012Shahnjayla K. Connors, PhD, MPH, CPHMolecular targets and mechanism of action of nutrient-derived agents

for cancer chemopreventionNational Institute of Health/National Cancer Institute - R01

Supplement Candidate

July 2011 – John Honeymeyer, Medical StudentHandbook of Cancer and Cancer Symptoms ManagementUniversity of South Florida, Morsani College of Medicine, Tampa, FL

May 2012 – Kaley McCrary, Medical StudentGrandmother’s Guidance: A proposal for a novel approach to the recruitment and retention of African American participants in prostate cancer clinical trials 2013 Scholarly Summer Project, University of South Florida, Morsani

College of Medicine, Tampa, FL

2015 - 2017 Andrew Koutnik, Surgical Fellow: Genitourinary OncologyAlternative Cancer Approach, University of South Florida, Morsani College of Medicine, Tampa, FL

Faculty Mentoring2004 – 2007 Mildred Fennel, PhD

of 59


Florida A & M University (FAMU) Center for Minority Prostate Cancer Training

and Research, Tallahassee, FL2004 – 2008 Folakemi Odedina, PhD (2006/2007 Fulbright Scholar, United States

of American, Department of State)Florida A & M University (FAMU) Center for Minority Prostate Cancer

Training and Research, Tallahassee, FL

2006 – 2009 Cecilia Jevitt, PhD, “Obesity in underserved migrant populations”,University of South Florida, College of Nursing, Tampa, FL

2008 – 2010 Folakemi Odedina, PhD (2006/2007 Fulbright Scholar, United States of American, Department of State), “Barriers and facilitators of clinical trial participation among African American men”National Institute of Health / National Cancer Institute (NIH/NCI) 1 R01 CA122060 – Minority Supplement

2010 – 2011 Iraida V. Carrion, PhD, LCSW, “Quality of life of Latino cancer survivors and

Families”, Assistant Professor, University of South Florida, School of Social

Work, Center for Equal Health, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL (MCC), University of South Florida, Tampa, FL (USF). 2009.

2010 – 2011 Cindy Tofthagen, PhD, A.R.N.P., “Vitamin E to prevent oxaliplatin induced

peripheral neuropathy”, Assistant Professor, University of South Florida, College

of Nursing, Tampa, FL, Center for Equal Health, H. Lee Moffitt Cancer Center

and Research Institute, Inc., Tampa, FL (MCC), University of South Florida,

Tampa, FL (USF)

2010 – 2012 Khaldoun Almhanna, MD, MPH, “Curcumin as a chemopreventive agent in the prevention of GERD-induced esophageal cancers”, H. Lee Moffitt Cancer Center and Research Institute, Inc., Gastriointestional Oncology Program (MMG), Tampa, FL

2012 – 2013 Shilpa Gupta, MD, “N-3 fatty acids in the prevention of prostate cancer”, H. Lee Moffitt Cancer Center and Research Institute, Inc., Genitourinary Oncology Program (MMG), Tampa, FL

2012 – 2013 Shailaja Raj, MD, “Body composition based dosing of chemotherapy regiments”,

of 59


H. Lee Moffitt Cancer Center and Research Institute, Inc., Hematology Oncology, Senior Adult Oncology Program (MMG), Tampa, FL

2015 – Andrew Leone, M.D., Surgical fellow, Genitourinary Oncology Program. H. Lee Moffitt Cancer Center and Research Institute, Inc., (MMG), Tampa, FL

Master’s Thesis1999 Susan Boro-Moyers, “Five-a-Day for Better Health: Development and Evaluation

of a Computer-Assisted Instructional Module in a Nutrition Education Program

for Health Professionals”, Masters of Public Health (MSPH), University of

South Florida, College of Public Health, Tampa, FL 2009 Annie DeMuth, “Anthropopmetrics, steroid hormones and lifestyle

factors as predictors of survival from prostate cancer”, Masters of Public Health (MSPH), University of South Florida, College of Public Health, Tampa, FL

2010 Kyle Dalton, “The validity of body composition vs. body surface area for determining dose of chemotherapy. Challenges and promises”, Masters of Biomedical Sciences, University of South Florida, College of Public Health, Tampa, FL. Currently working on Medical Doctorate at the University of Florida, College of Medicine, Gainesville, FL

2010 Jessica Wooden, “Cognitive impairment in cancer patients treated with chemotherapy”, Masters of Neuroscience, University of South Florida, College of Medicine, Tampa, FL

2010 Sabrina Brem, “Symptoms of Cancer and Cancer Treatment”, Masters, Columbia

University, New York, NY. Currently working on PhD at Columbia University.

2012 – Kaley McCrary, Medical Student. Grandmother’s Guidance: A proposal for a novel approach to the recruitment and retention of African American participants in prostate cancer clinical trials. Medical Student Years I-IV: USF Morsani College of Medicine. Tampa, FL

2014 – Roshni Patel, SPARK Pre-Med (6 year Medical Program). USF Morsani College of Medicine. Tampa, FL

2015 – Ramon Pineda, Prostate Cancer: Characterizing early lesions. Masters of Public Health, University of South Florida, College of Public Health, Tampa, FL

of 59


2015 – Brendan Franklin. Association of body composition to breast density characteristics. University of South Florida, Tampa, FL

Dissertation1998 – 2000 Greg Holmes, “Pyridoxine (B6) in the treatment of Carpal Tunnel

Syndrome”, Masters of Nursing, University of South Florida, College of Nursing, Tampa, FLDoctoral Dissertation Committee Member

2000 Arlene Calvo, “Social Construction of Cervical Cancer Screening AmongWomen in Panama City,” College of Public Health (PhD), University of South Florida, Tampa, FL. Doctoral Dissertation Committee Member

2006 – 2009 Karen Besterman-Dahan, “Cultural factors contributing to colorectal cancer screening in Ashkenazi Jewish cohorts in Tampa”, Medical Anthropology, University of South Florida, College of Medical Anthropology, Tampa, FL.Doctoral Dissertation Committee Member

2009 – 2012 Teresa Crocker, “Anthropological perspectives of barriers and facilitators of

participation in clinical trials”, Medical Anthropology, University of South Florida, College of Medical Anthropology, Tampa, FL. Doctoral Dissertation Committee Member

2012 – 2015 Elizabeth Handling. “Mediation and moderation analysis of nutrition, inflammatory biomarkers, and cognition in older adults”. School of Aging Studies, College of Behavioral and Community Sciences, University of South Florida, Tampa, FL. Doctoral Dissertation Committee Member

2016 Li-Ting Huang, “Investigating the Mutual Effects of Depression and Spiritual Well-being on Quality of Life in Hospice Patients with Cancer and Family Caregivers Using the Actor-Partner Interdependence Model”. College of Nursing, University of South Florida. Doctoral Dissertation Committee Member

Honors and Awards

1972 Cornelius Memorial Gold Medal for Best Student in Biology1976 Cornelius Memorial Prize for Best Student in Nutrition, Graduating Class

of 1976, Madras University, Madras, India1993 Distinguished Dietitian, Tampa Dietetic Association, Tampa, FL1994, 1995, 1997 Nominee for Medallion Award for Excellence in Research, American

of 59


Dietetic Association1994 Executive of the Year, Professional Secretaries International® -

City Center Chapter, Tampa, FL

1997 Fellow of the American Dietetic Association2000 Best Oncology Nursing Chapter Meeting, Oncology Nursing

Society - Greater Tampa Chapter, Tampa, FL2003 Leader – Team Award, Spirit of Moffitt Cancer Center, H. Lee

Moffitt Cancer Center and Research Institute, Inc., Tampa, FL 2006 Leader – Team Award Winner, H. Lee Moffitt Cancer Center

and Research Institute, Inc., Tampa, FL2012 Book of the Month – Kumar NB “Nutritional Management of

Cancer Treatment Effects”, University of South Florida, Morsani College of Medicine, Tampa, FL

2012 Outstanding Faculty Performance Award, Population Sciences Division, Cancer Epidemiology Department, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

2014 Team Award – TeleTalk Team, Spirit of Moffitt Cancer Center, H. Lee

Moffitt Cancer Center and Research Institute, Inc., Tampa, FL 2014 – Fellow, Academy of Nutrition and Dietetics2015 Outstanding Faculty Performance Award, Population Sciences

Division, Cancer Epidemiology Department, H. Lee Moffitt Cancer Center and Research Institute, Inc., Tampa, FL

2015 Nominated, 2015 Moffitt Physician of the Year

Research Support

Current FundingExternal Grants

(1) Account # Gateway G13-200 Kumar (PI)Dates: 04/03/2013 – 07/31/2016Source: Gateway FoundationTitle: A Phase II clinical trial to ameliorate symptoms of

cognitive impairment in women treated with chemotherapy for breast cancer: The COGNUTRIN trial

Percentage of Effort: 10%Role in Study: Principal InvestigatorPurpose of Research: The primary aim of this study is to evaluate the safety

and effectiveness of a novel combination agent

of 59


COGNUTRIN in ameliorating symptoms of “Chemobrain”.

Total Direct: $215,000

(2) Account # 1 R21 CA179659-01 Chornokur (PI)Dates: 11/01/2014 – 10/31/2016Source: National Institute of Health (NIH)Title: Obesity and prostate cancer risk in Black and White men:

a functional approachEffort: 4%Role in Study: Co- InvestigatorTotal Direct: $ 275,000Total Amount of Award: $ 403,137

(3) Account # PI: N01 Brown (PI)Dates: 07/1/2015 – 6/30/2020Source: National Institute of Health (NIH)/National Cancer

Institute (NCI)Title: UT MD Anderson Cancer Center Cancer Prevention Agent

development Program: Early Phase Clinical Research Consortium;

Contract NO.: HHSN261201200034I Moffitt Cancer Center

Role in the study: Site PIProposal Title: Brief Exposure Early Phase II Clinical Evaluation of

Metformin for Breast Cancer Prevention in BRCA1 Mutation Carriers

Effort: 5%Role in Study: Principal InvestigatorAnnual Direct: $225,341Total Direct: $422,368 Total Grant: $647,709

(4) Account #: 2 T32 CA147832-06 Kanetsky (PI)

Dates: 07/13/2015 – 06/30/2020Source: National Institute of Health (NIH)/National Cancer

Institute (NCI)Proposal Title Moffitt Postdoctoral Training Program in Molecular EpidemiologyPercentage of Effort: 0%Role in the Study: MentorTotal Direct: $ 899,784Total Amount of Award: $ 968,168

Pending FundingExternal Grants(1) Account #: 1 R21 CA177564-01 Kumar (PI)Dates: 07/01/2013 – 06/30/2015

of 59


Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Proposal Title: Multimodal Approach in the Treatment of Cancer Cachexia Effort: 30%Role in Study: Principal InvestigatorTotal Direct: $ 275,000.00Total Amount of Award: $ 453,949.00Percentile Score 1st submission: 34

(2) Account #: 1 R21 CA177566-01 Kumar (PI)Dates: 07/01/2013 – 06/30/2015Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Proposal Title: Botanicals and Biologics in Ameliorating Chemobrain Effort: 30%Role in Study: Principal InvestigatorTotal Direct: $ 275,000.00Total Amount of Award: $ 455,483.00. Percentile Score 1st submission: 37

(3) Account #: 1 R01 CA187210-01 Kumar/Kakarala (MPI) Dates: 07/01/2014 – 06/30/2019 Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Proposal Title: Brief Exposure Early Phase II Clinical Evaluation of

Metformin for Breast Cancer Effort: 30%Role in Study: Principal InvestigatorTotal Direct: $2,995,707 Total Grant: $3,885,312

(4) Account: 1UM1 CA190001-01 Kumar/Roetzheim (MPI)Dates: 09/01/2014 – 08/31/2019Source: National Institute of Health (NIH)/National Cancer

Institute (NCI)

Title of Project : Moffitt NCORP Research base (MNCORPB)Percentage of Effort: 50%Role in the Study: PITotal Direct Costs: $14,787,664Percentile Score 1st submission: 47

(5) Account#: 1R01 CA200621-01 Kumar/Alexandrow (MPI)Dates: 09/01/2015 – 08/31/2019

of 59


Source: National Institute of Health (NIH)Proposed Title: Chemoprevention of Lung CancerEffort: 25%Role in Study: CO-Principle InvestigatorTotal Direct Costs: $2,870,389

(6) Account#: NA Phelan /Kumar (MPI)Dates: 03/01/2016 – 02/28/2021Source: Florida Department of HealthProposed Title: Identification of Prostate Cancer Precursor Lesion BiomarkersEffort: 15%Role in Study: Co-PITotal Direct Costs: $1,325,825

(7) Account#: 1R21 CA208915-01 Kumar (PI)Dates: 07/01/2016 – 06/30/2018Source: National Institute of Health (NIH)Proposed Title: A Randomized, phase II clinical trial of Sulforaphane in

Bladder Cancer ChemopreventionEffort: 11%Role in Study: Principle InvestigatorAnnual Direct Costs: $137,500Total Direct Costs: $275,000Total Amount Requested: $459,258

(8) Account#: 1R01 CA208052-01 Kumar/Sellers (MPI)Dates: 07/01/2016 – 06/30/2021Source: National Institute of Health (NIH)Proposed Title: Early-Life Factors in Preadolescence and Cancer Development

Later in LifeEffort: 30%Role in Study: CO-Principle InvestigatorAnnual Direct Costs: $659,219Total Direct Costs: $3,296,050Total Amount Requested: $5,553,924

(9) Account #: NA Kumar/Alexandrow (MPI)

Dates: 09/01/2016 – 08/31/2020Source: National Institute of Health (NIH)/National Cancer

Institute (NCI)Proposal Title: Broad Spectrum Approach for Chemoprevention of Lung

Cancer in Former SmokersEffort: 20%Role in the Study: Co-Principal InvestigatorAnnual Direct Costs: $

of 59


Total Direct Costs: $1,999,320Total Amount Requested: $2,925,648

(10) Account #: NA Park/Kumar (MPI)Dates: 10/01/2016 – 09/30/2019Source: United States Army/Department of Defense Proposal Title: Early Lesions (HGPIN ASAP) to Prostate Cancer:

Validation of an Integrated Set of Biomarkers for Risk Stratification and Management of Early Lesions.

Effort: 7%Role in the Study: Co-Principal InvestigatorAnnual Direct Costs: $122,416Total Direct Costs: $375,000Total Amount Requested: $631,875

Internal Grants(11) Account #: NA Kumar/Phelan (MPI)Dates: 06/01/2015 – 05/30/2016Source: Miles for MoffittProposal Title: Comparative evaluation of epidemiological, histopathological,

biochemical, clinical and molecular characteristics of preneoplastic lesions in African American men (AAM) and White men (WM) diagnosed with high grade prostatic intraepithelial neoplasia (HGPIN)and atypical small acinar proliferation (ASAP): Implications for biomarker identification, rick classification and targeted interventions

Effort: 5%Role in Study: Principal InvestigatorTotal Direct: $50,000Total Amount of Award: $99,357

Completed FundingExternal Grants(1) Account # NA Schapira/Kumar (MPI)Dates: 07/01/1987 – 06/30/1990Source: H. Lee Moffitt Cancer Center and Research Institute, Inc.Title: Body fat, Body Composition and Breast & Endometrial Cancer

RiskPercentage of Effort: 100%Role in Study: Co-PITotal Direct: $200,000

(2) Account # NA Schapira/Kumar (MPI)Dates: 07/01/1990 – 06/30/1992Source: H. Lee Moffitt Cancer Center and Research Institute, Inc.Title: Body fat, Body Composition steroid Hormones and Breast

& Endometrial Cancer Risk

of 59


Percentage of Effort: 100%Role in Study: Co-PITotal Direct: $200,000

(3) Account # NA Schapira/Kumar (MPI)Dates: 07/01/1992 – 06/30/1997Source: American Cancer SocietyTitle: Body composition patterns and hormonal risk in familiesPercentage of Effort: 30%Role in Study: Co-PITotal Direct: $100,000

(4) Account # AICR Kumar (PI)Dates: 07/01/1997 – 06/30/2000Source: American Institute of Cancer ResearchTitle: The specific role of genistein in reducing hormonal and

proliferative risk parameters in prostate cancerPercentage of Effort: 30%Role in Study: Principal InvestigatorTotal Direct: $140,000

(5) Account # BC9712951 Kumar (PI)Dates: 12/01/1998 – 06/30/2002Source: Department of DefenseTitle: Weight Gain in Breast Cancer Patients on Chemotherapy:

Exploring Hormonal, Body Composition and behavioral mechanisms

Percentage of Effort: 30%Role in Study: Principal InvestigatorTotal Direct: $250,000

(6) Account # 1 RO3 CA72588-01A1 Kumar (PI)Dates: 12/01/1998 – 06/30/2002Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)NIH/NCITitle: The specific role of genistein in estrogen metabolismPercentage of Effort: 30%Role in Study: Principal InvestigatorTotal Direct: $150,000Total Amount of Award: $150,000

(7) Account # 9704 Brem (PI)Dates: 07/01/1999 – 06/01/2001Source: National Cancer Institute (NCI)/ New Approaches to Brain

Tumor Therapy (NABTT)Title: Phase II study of Penicillamine and reduction of Cooper

for Angiosupressive Therapy of Adults with Newly Diagnosed Glioblastoma

of 59


Percentage of Effort: 5%Role in Study: Co-InvestigatorTotal Direct: NATotal Amount of Award: NA

(8) Account # SELECT Pow-Sang (PI)Dates: 12/01/2001 – 12/01/2003Source: NI-SWOGTitle: Selenium and Vitamin E Prevention TrialPercentage of Effort: 5%Role in Study: Co-InvestigatorTotal Direct: $28,290

(9) Account # 1U10 CA81920 Krischer (PI)Dates: 05/2002 – 11/30/2006Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: The Specific Role of Isoflavones in Reducing Prostate Cancer Risk Percentage of Effort: 10%Role in Study: Co-Investigator/Study ChairTotal Direct: $2,154,512Total Amount of Award: NA

(10) Account # 1U10 CA81920 Krischer (PI)Dates: 05/2002 – 11/30/2006Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: A Randomized Pilot Clinical Trial of the Action of

Isoflavones and Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy

Percentage of Effort: 10%Role in Study: Co-Investigator/Study ChairTotal Direct: $2,154,512Total Amount of Award: NA

(11) Account # 1U10 CA81920 Kumar (PI)Dates: 05/2002 – 11/30/2006Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: Treatment of Chemotherapy-Induced Nausea with

Acupressure: A Phase III Trial Percentage of Effort: 5%Role in Study: Study Chair-H. Lee Moffitt Cancer Center and Research

Institute, Inc.Total Direct: $2,154,512Total Amount of Award

of 59


(12) Account # PC030462 Odedina/Kumar (Co-PI)Dates: 03/01/2004 – 02/28/2007Source: Department of DefenseTitle: Florida A & M University (FAMU) Center for Minority

Prostate Cancer Training and Research: A Collaborative Program between FAMU and the H. Lee Moffitt Cancer Center and Research Institute, Inc. (MCC)

Percentage of Effort: 10%Role in Study: Co-Principal InvestigatorTotal Direct: $805,814 (Moffitt subcontract $150,921)Total Amount of Award: Moffitt subcontract $246,001

(13) Account # PC051389 Kumar (PI)Dates: 01/01/2006 – 1/29/2009Source: Department of DefenseTitle: Project INSPIRE – HBCU Undergraduate Collaborative

Summer Training Program to inspire students in Prostate Cancer

ResearchPercentage of Effort: 16%Role in Study: Principal InvestigatorTotal Direct: $200,000 $116,844Total Amount of Award: $126,192

(14) Account # 1R21 CA11789701 Meade (PI)Dates: 06/12/2006 – 05/31/2008Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: Relevant Education and Communications for Hispanics Percentage of Effort: 3%Role in Study: Co-InvestigatorTotal Direct: $209,000 $206,245Total Amount of Award: $336,179

(15) Account # NA Kumar (PI)Dates: 07/01/2007 – 06/30/2009Source: Reliant PharmaceuticalsTitle: A Phase II clinical trial of n-3 fatty acids in cancer cachexiaPercentage of Effort: 3%Role in Study: Principal InvestigatorTotal Direct: $240,000Total Amount of Award: $312,000

(16) Account # 1R01 CA122060-01A1 Kumar (PI)Dates: 07/01/2007 – 06/30/2015 Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)

of 59


Title: A Phase II Clinical trial of Polyphenon E in Prostate CancerPercentage of Effort: 32.5%Role in Study: Principal InvestigatorPurpose of Research: The primary aim of this study is to evaluate the safety and

effectiveness of Polyphenon E in preventing progression of HGPIN

and/or ASAP to prostate cancer. Total Direct: $2,933,794Total Amount of Award: $3,649,974

(17) Account # 1R01 CA122060-Supplement Kumar (PI)Dates: 08/01/2008 – 07/31/2010Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: A Phase II Clinical trial of Polyphenon E in Prostate

Cancer: Minority SupplementPercentage of Effort: 0%Role in Study: Principal Investigator/MentorPurpose of Research: To evaluate the barriers and facilitators of clinical trial

participation among African American men. Training: Minority candidate: Folakemi Odedina, Ph.D. in training.Total Direct: $200,000Total Amount of Award: $338,000

(18) Account # 1P20 MD003375-01Roetzheim/Green(PI)

Dates: 04/01/2009 – 03/31/2011Source: National Institute of Health (NIH)/National Center on

Minority Health and Health Disparities (NCMHD)Title: Education and Training CorePercentage of Effort: 5%Role in Study: Core Co-Leader

(19) Account # 1P20 MD003375-01 Roetzheim/Green (PI)Dates: 04/01/2009 – 03/31/2014 (NCE)Source: National Institute of Health (NIH)/National Center on

Minority Health and Health Disparities (NCMHD)Title: Research CorePercentage of Effort: 2.5%Role in Project: Core Co-LeaderTotal Direct: $33,806/year

(20) Account # 1P20 MD003375-01 Roetzheim/Green (PI)Dates: 04/01/2009 – 03/31/2014 (NCE)Source: National Institute of Health (NIH)/National Center on

Minority Health and Health Disparities (NCMHD)

of 59


Title: Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness and mechanism of action between African American and Caucasian men.

Percentage of Effort: 20%Role in Study: Principal Investigator/Study ChairPurpose of Research: To compare the efficacy and safety of an intervention

with purified isoflavone in modulating intermediate endpoint biomarkers of prostate cancer progression between African American and Caucasian men diagnosed with clinically localized prostate cancer.

Total Direct: $94,074/year

(21) Account#: 1 R25 CA147832 Egan (PI)Dates: 7/1/2010 – 6/30/2015Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: Moffitt Postdoctoral Training Program in Molecular & Genetic

EpidemiologyEffort: NoneRole in the study: MentorTotal Direct Costs: $2,114,139Total Amount of Award: $2,283,270

(22) Account # 1P20 MD003375-01 Kumar A (PI)Dates: 08/01/2010 – 07/30/2011Source: USF/Moffitt Center for Equal Health PilotTitle: Internal and External Validity of Prostate Cancer Randomized

Controlled TrialsPercentage of Effort: 5%Role in Study: Co-InvestigatorPurpose of Research: The primary aim of this study is to evaluate the Internal

and External Validity of Prostate Cancer Randomized Controlled Trials

Total Direct: $17,921Total Amount of Award: $20,000

(23) Account # 1R01 CA122060-Supplement Kumar (PI)Dates: 08/01/2010 – 07/31/2012Source: National Institute of Health (NIH)/National Cancer Institute

(NCI)Title: A Phase II Clinical trial of Polyphenon E in Prostate

Cancer:Minority Supplement

Percentage of Effort: 0%Role in Study: Principal Investigator/Mentor

of 59


Purpose of Research: To evaluate the effects of Polyphenon E treatment on NFκB and

C/EBPβ expression during prostate cancer progression in human

samplesMinority candidate: Shahnjayla Connors, Ph.D. in training.Total Direct: $162,668Total Amount of Award: $271,656

(24) Account # W81XWH-11-1-0376 Chornokur (PI)Dates: 06/01/2011 – 05/31/2013Source: United States Army/Department of Defense Title: Comprehensive Population-Specific Marker Panel for Early

Prostate Cancer Diagnostics and Risk AssessmentPercentage of Effort: 0%Role in Study: Mentor/Co-IPurpose of Research: The purpose of this study is to evaluate a feasibility of

using DETECT as a reliable approach to estimate the risk and/or detect prostate cancer early in African American Men ultimately eliminating the disparity in prostate cancer morbidity and mortality.

Total Direct: $115,000Total Amount of Award: $124,200

Internal Grants(25) Account # NA Kumar (PI)Dates: 09/03/2012 – 08/31/2013Source: Moffitt Merit SocietyTitle: A Phase II clinical trial to ameliorate symptoms of

cognitive impairment in women treated with chemotherapy for breast cancer: The COGNUTRIN trial

Percentage of Effort: 0%Role in Study: Principal InvestigatorTotal Direct: $10,000Total Amount of the Award: $10,000

(26) Account #: NA Kumar (PI)Dates: 03/01/13 – 06/30/2013Source: Cancer Epidemiology Program FundsTitle: Metformin in BRCA1 CarriersEffort: 0%Role in Study: Principal InvestigatorTotal Direct: $10,000Total Amount of Award: $10,000

Contracts(1) Account # BYM338X2202 Kumar (PI)Dates: 08/21/2011 – 08/31/2013Source: Novartis Pharmaceuticals

of 59


Title: BYM338X2202 in Cancer CachexiaPercentage of Effort: 10%Role in Study: Principal InvestigatorPurpose of Research: The primary aim of this study is to evaluate the safety

and effectiveness of a novel agent BYM338X2202 in preventing progression of cancer cachexia.

Total Direct: $508,900

(2) Account # 40-2011-WS-Cancer ChemopreventionKumar (PI)Dates: 01/01/2012 – 12/31/2012Source: Indo-US Science and Technology Forum, Fulbright HouseTitle: Accelerating Botanicals and Biologics Agent

Development Research for Cancer Chemoprevention, Treatment and Survival.

Percentage effort: 0%Role in Study: PIPurpose of Research: To establish a working consortium of trans-disciplinary

scientists from India and USA to develop and implement team-science projects to evaluate and translate the science of botanical and biologic drug discovery from bench to bedside.

Total Direct: $50,000Total Amount of the Award: $50,000

Service

Service at H. Lee Moffitt Cancer Center and Research Institute, Inc. & Research Institute1. Administrative Appointments1994 – 2005 Member, Performance Improvement Committee1994 – 1996 Member, Behavioral Sciences Review Committee1994 – Member, Breast Cancer Research Committee1994 – Member, In Residence Moffitt Research Institute1998 – 2003 Member, Joint Commission, Accreditation, Heath Care, Organization

(JCAHO) Implementation Team2000 – 2003 Member, Faculty Search Committee, Cancer Control Program2000 – 2004 Member, Moffitt Clinic Organization group (MCOG)2001 – 2008 Member, Today’s Tomorrows – Editorial Board2005 – 2008 Member, Total Cancer Care Evidence-Based Medicine Workgroup2006 – 2008 Member, Total Cancer Care Diversity Workgroup2006 – 2008 Member, Integrative Medicine Leadership Group2007 – 2008 Member, Study Section, H. Lee Moffitt Cancer Center and Research

Institute, Inc., Integrative Medicine Pilot Research Grant Program2007 – 2014 Member, Education Steering Committee2009 – 2010 Member, Moffitt Research Institute Operations Task Force2010 – 2012 Member, Faculty Advisory Committee2011 – 2014 Judge, Moffitt Scientific Symposium

of 59


2011 – 2013 Vice-Chair, Division of Population Sciences, Promotion and Tenure

Committee2013 – 2015 Chair -Division of Population Sciences, Promotion and Tenure

Committee2013 – 2015 Member- Oncologic Sciences, USF/Moffitt, Promotion and Tenure

Committee2013 – 2015 Member, Trial and Studies Taskforce 2015 – Member, Faculty Search Committee, Cancer Epidemiology

2. University of South Florida Service1991 – 1994 Designing Kitchens that Serve Children, University of South Florida,

College of Public Health, Department of Community and Family Health, Tampa, FL

1993 – 1995 Advisory Board Member, Institute on Black Life1993 – 1997 Advisory Board Member, Aging Studies Initiative2001 – 2010 Board Member, University of South Florida, Institutional

Review Board, Medical Board (2 terms), Tampa, FL2003 – 2013 Member, Quality Monitoring Subcommittee, University of South Florida,

Institutional Review Board, Medical Board, Tampa, FL2004 – 2005 Appointed Member, Project to Advance Clinical Education

Subcommittee on Integrated Longitudinal Curriculum, University of South Florida, College of Medicine, Tampa, FL

2010 – 2011 Consultant Reviewer, University of South Florida Institutional Review Board2011 – 2012 Faculty Search Committee, Department of Anthropology, University of South

Florida, College of Arts and Sciences, Tampa, FL2012 – 2014 Faculty Council, University of South Florida, Morsani College of Medicine,

Tampa, FL

3. Service at Other Universities2004 – 2008 Co-Leader, Florida A & M University (FAMU) Center for Minority

ProstateCancer Training and Research, Tallahassee, FL

2005 – 2007 Member, Program Advisory Committee, Hillsborough Community College to Florida A & M University Bridges to the Pharmaceutical Sciences

Program, Tampa, FL2006 – 2008 Member, External Scientific Advisory Board, Howard University Cancer

Center, Washington, DC2012 – 2013 Consultant, University of Alabama – Birmingham, Division of

Preventive Medicine, Birmingham, AL

Professional1. Positions held in Professional Organizations

of 59


1984 – 1985 Chairman, Committee on Dietetic Educators, Tampa Dietetic Association

Chairman, Committee on Dietetic Educators and Clinical Nutrition and Dietetics,

Tampa Dietetic Association1986 – 1987 Board Member, Florida Gulf Coast Chapter, American Society for

Hospital Food Service Administrators1986 – 1989 Chairman, Committee on Quality Assurance, Tampa Dietetic Association

(Three Terms)1989 Chairman, Pre-convention Seminar, Florida Dietetic Association 1992 – 1993 Chairman, Education & Research, Tampa Dietetic Association1996 Member, Nominating Committee, Florida Dietetic Association2012 – 2013 Member of the Board of Directors, Society of Integrative Oncology

2. Editorial Responsibilities (Current)1996 – Reviewer, Cancer Detection & Prevention1997 – Reviewer, Cancer Control1998 – Reviewer, Cancer1999 – Reviewer, International Journal of Obesity2001 – Reviewer, Carcinogenesis2002 – Reviewer, Nature2002 – 2005 Founding Editor-in-Chief, International Journal Evidence-Based Integrative

Medicine2004 – Reviewer, BioMedical Central (BMC) Complementary and Alternative Medicine2004 – Reviewer, Indian Journal of Medical Sciences2005 Reviewer, American Dietetic Association (ADA) Pocket Guide to

Drug/ Supplement Interactions2005 – Reviewer, European Journal of Clinical Nutrition2005 – Reviewer, International Journal of Cancer2005 – Reviewer, National Cancer Institute – Chemotherapy & You2006 – Reviewer, Molecular and Cellular Biochemistry2006 – Reviewer, Obesity Research2006 – 2012 Associate Editor/Editorial Board Member, International Journal Society of

Integrative Oncology 2007 – Reviewer, American Journal of Epidemiology2007 – Reviewer, Breast Cancer Research & Treatment2007 – Reviewer, Cancer Epidemiology Biomarkers and Prevention2008 – Reviewer, American Journal of Clinical Nutrition2008 – Nutrition and Cancer2009 – Reviewer, Journal of Clinical Oncology2010 – Reviewer, Journal of Contemporary Clinical trials2012 Reviewer, Journal of Medical Care 2012 – Reviewer, Cancer Prevention Research2012 – Reviewer, World Medical & Health Policy2013 – Reviewer, Journal of the National Cancer Institute (NCI)2015 – Reviewer, Cancer Prevention Research

of 59


2015- Reviewer, Seminars in Cancer Biology2015- Reviewer, Journal of Clinical Epidemiology2015- Reviewer, European Journal of Cancer Prevention

3. Other Significant Service/Educational Leadership at the National Level1999 – 2005 Member, National Comprehensive Cancer Center Advisory Committees

National Comprehensive Cancer Network-Nutritional Guidelines Panel2002 – 2005 Chair, Subcommittee, Nutritional Symptoms Management

Guidelines, NationalComprehensive Cancer Network-Nutritional Guidelines Panel

2005 Panel Member/Presenter, The promises and perils of lycopene/tomato supplementation and cancer prevention – (National Institute of Health (NIH)/National Cancer Institute (NCI)/National Center for Complementation Alternative Medicine (NCCAM) / Office of Dietary Supplements (ODS) / Federal Drug Administration (FDA)) NIH/NCI/NCCAM/ODS/FDA Panel, February 17-18, 2005

2005 – 2008 Panel Member, National Institute of Health (NIH)/National Cancer Institute (NCI) Study Section PAR 04-020

2005 – 2008 Panel Member, N National Institute of Health (NIH)/National Cancer Institute

(NCI) Study Section, Special Emphasis Panel/Scientific Review Group 2006/01

ZCA1 SRRB-K (J2) 2005 – Panelist, Diagnosis and Management of Lung Cancer: American

College of Chest Physicians: Evidence-Based Guideline (2nd Edition), Health and Science Policy Committee

2006 Co-Author, Program Announcement, National Institute of Health (NIH)/National

Cancer Institute (NCI) Cancer Therapy Evaluation Program: Clinical Trials in

Oncology Nutrition (CONC)2007 – 2008 Founding Member, Clinical Nutrition Research Consortium Panel, National

Cancer Institute, Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute (NCI)

2007 – Member, Integrative Oncology Practice Guidelines Committee2009 – Panel Member, 2009 Clinical Practice Guidelines Committee, Society of Integrative Oncology2009 – Invited Member, Botanicals in Clinical Trials Workgroup. National

Institute of Health (NIH)/National Cancer Institute (NCI)2009 – Review Panel, Nutrients - Chemoprevention Study Section National

Institute of Health (NIH)/National Cancer Institute (NCI). 2009/10 ZRG1 OTC-K

2009 – Review Panel, Risk Prevention and Health Behavior (RPHB) Study Section

National Institute of Health (NIH)/National Cancer Institute (NCI) ZRG1

of 59


RPHB A-58 and ZRG1 RPHB E-52009 – Member, DOD - Congressionally Directed Medical Research Program (CDMRP)

Prostate Cancer (PCRP) Study Section2010 – Member, Cancer Prevention Committee, SWOG. Chair: Dr. Frank Meyskens2010 – Member, Study Section: NIH-NCI-ZCA1 RPRB-7 (J1) P Disparities, Cancer Risk

and Prognostic Factors, PO12010-2010 – Member, Cancer Center Review Panel (Cancer Center Support Grant,

P30) National Institute of Health (NIH)/National Cancer Institute (NCI)

2010 – Author, Health & Science Policy (HSP) Integrative Oncology Chapter of the Lung

Cancer Guidelines Committee2011 – Member, Indo-US cooperation in life sciences Advisory Board (Cancer Botanical

Drug Development), National Cancer Institute (NCI)2011 – Panelist, China - US Cancer Symposium Panel on Traditional Chinese Medicine,

National Cancer Institute (NCI)2012 Chair, DOD - Congressionally Directed Medical Research Program

(CDMRP) Prostate Cancer (PCRP) Study Section 2012 Consultant, Cancer-Free label Act. Congressman Ted Deutch 2012 – 2015 Member, PDQ Cancer Complementary and Alternative Medicine Editorial Board,

National Institute of Health (NIH)/National Cancer Institute (NCI)2012 – Consultant, Novel Therapeutics for Cancer Supportive Care. Frankel

Group, New York, NY2012 – Member, Study Section - French National Cancer Institute - Hospital Clinical

Research Program - PHRC 20122012 – Member, Study Section. National Institute of Health (NIH)/National

Institute of Nursing Research (NINR) NIH-NINR: RFA-12-010 entitled “Early detection and prevention of mild cognitive impairment’’ (R01 mechanisms)

2013 Member, R30 Review Panel, National Cancer Institute-A, RTRB-A E12013 Faculty, International consortium: Seminars in Cancer Biology Apoptosis

Theme Review. The Halifax Project. 2013 Member, International Organizing Committee. PHYTOCONGRESS –

2013: India2013 Member, Health Disparity Panel, Department of Defense – Prostate

Cancer Research Program, Baltimore, MD2013 – Ad Hoc Member, Study section. NIH-NCI-CDP. National Institute of

Health (NIH)/National Cancer Institute (NCI), Chemo/Dietary Prevention.

2014 Member, Review Panel, Omnibus R03/R21 – Tumor Immunology, National

Institute of Health (NIH) / National Cancer Institute (NCI)

of 59


2014 Member, Review Panel, Omnibus R03/R21 – National Institute of Health (NIH)

National Cancer Institute (NCI)2014 Member, Review Panel, Prostate Cancer Research Program,

Summer Training Program, Department of Defense, Baltimore, MD2014 Consultant, Department of Health, State of New York2014 – Member, Peer Review Panel, Cancer Prevention & Research Institute

of Texas (CPIRT) Research Program, TX2014 – Consultant Board Member II, Schulman Associates IRB, Sunrise, FL2014 – Member, PAR-13-386: “Cancer Center Support Grants (CCSGs) for

NCI-designated Cancer Centers” (P30), National Cancer Institute (NCI)

2015 – Reviewer, GMaP Junior faculty grants (RO1)2015 – Member, National Institute of Health (NIH)/National Cancer Institute

(NCI), NIH-NCI NO1- University of Texas, M.D. Anderson Cancer Center Cancer Prevention Agent Development Program: Early Phase Clinical Research Consortium, Houston, TX

2015 – Member, National Institute of Health (NIH)/National Cancer Institute (NCI) Eastern Cooperative Oncology Group (ECOG) and the American College of Radiology Imaging Network (ACRIN) (ECOG-ACRIN) NIH-NCI ECOG-ACRIN: Prevention Committee

2015 – National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) - Special Emphasis Panel PAR-13-150 & PAR-13-151, “Investigator Initiated Clinical Trial Applications (R34) and NIAID Clinical Trial Implementation Cooperative Agreement (U01)”

2015 – Chair, National Cancer Institute Special Emphasis Panel ZCA1 RPRB-M J1 S2016 – Member, PDQ Cancer Complementary and Alternative Medicine Editorial Board, National Institute of Health (NIH)/National Cancer Institute (NCI) (2nd Term)2016 – Member, Extramural Research Faculty: National Cancer Institute’s

(NCI) Center for Global Health - NCI-India Delegation 2016 Chair, National Cancer Institute R01 ZCA1 RPRB-M (M9) Study

Section

State of FloridaOctober 2014 – September 2017 Member, Board of Directors of Living

Healthy in Florida, Department of AgricultureCommunity2005 – 2008 Member, National Advisory Board for Health, Museum of Science & Industry,

Tampa, FL2006 – 2008 Member, Board of Directors, PACE Center for Girls, Tampa, FL2006 – President, Class of 2006, Leadership Tampa, Tampa Chamber of Commerce,

Tampa, FL2006 – Member, Tampa Chamber of Commerce, Tampa, FL

of 59


Professional Association Memberships

1998 – The Academy of Nutrition and Dietetics(Fellow of the Academy of Nutrition and Dietetics)

2005 – American Association of Cancer Research2007 – American Society of Clinical Oncology

Peer-Reviewed Publications

1. Schapira DV, Kumar NB, McMillan SC, Lyman G. The Public's Knowledge of Dietary Recommendations of Food Labeling. Journal of cancer education: the official journal of the American Association for Cancer Education. 1987; 4(2):282.

2. Schapira DV, Kumar NB, Lyman GH, Baile W. The Efficacy of Long & Short Term Dietary Interventions. Journal of cancer education: the official journal of the American Association for Cancer Education. 1988; 3:300.

3. Schapira DV, Kumar NB, Lyman GH, Cox C. Body Fat Distribution and Breast Cancer Risk. Breast cancer research and treatment. 1988; 12:142.

4. Schapira DV, Kumar NB, Lyman GH, Baile W. Health Attitude and Dietary Change. Journal of cancer education: the official journal of the American Association for Cancer Education. 1989.

5. Schapira DV, Kumar NB, Lyman GH, Cox CE. Body Fat Distribution and Breast Cancer Risk. Cancer detection and prevention. 1989; 14:96.

6. Schapira DV, Kumar NB. Disease prevention. A link missing. Arch Intern Med. 1989 Jun;149(6):1253-4. PMID: 2730245.

7. Schapira DV, Kumar NB, Lyman GH, McMillan SC. The value of current nutrition information. Prev Med. 1990 Jan;19(1):45-53. PMID: 2320559.

8. Schapira DV, Kumar NB, Lyman GH, Cox CE. Abdominal obesity and breast cancer risk. Ann Intern Med. 1990 Feb 1;112(3):182-6. Erratum in: Ann Intern Med 1990 May 15;112(10):798. PMID: 2297194.

9. Schapira DV, Kumar NB, Lyman GH. Serum cholesterol reduction with tamoxifen. Breast Cancer Res Treat. 1990 Nov;17(1):3-7. PMID: 2095926.

10. Schapira DV, Kumar NB, Lyman GH, Cox CE. Scientific Abstract - Effect of Body Fat Distribution on Lymph Node and Estrogen Receptor Status at Diagnosis. American Society of Clinical Oncology. 1990; 187.

of 59


11. Schapira DV, Kumar NB, Lyman GH. Scientific Abstract - The Effect of Tamoxifen Therapy on Serum Cholesterol. American Society of Clinical Oncology. 1990; 186.

12. Schapira DV, Kumar NB, Lyman GH, Cox CE. Obesity and body fat distribution and breast cancer prognosis. Cancer. 1991 Jan 15;67(2):523-8. PMID: 1985744.

13. Schapira DV, Kumar NB, Lyman GH. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer. 1991 Apr 15;67(8):2215-8. PMID: 2004343.

14. Schapira DV, Kumar NB, Lyman GH. Estimate of breast cancer risk reduction with weight loss. Cancer. 1991 May 15;67(10):2622-5. PMID: 2015563.

15. Schapira DV, Kumar NB. Diet, obesity, fat distribution and cancer in women. J Am Med Women’s Assoc. 1991 Jul-Aug;46(4):126-30. Review. PMID: 1651963.

16. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA. 1991 Oct 2;266(13):1808-11. PMID: 1890709.

17. Schapira DV, Kumar NB, Lyman GH, Baile WF. The effect of duration of intervention and locus of control on dietary change. Am J Prev Med. 1991 Nov-Dec;7(6):341-7. PMID: 1790041.

18. Schapira DV, Kumar NB, Clark RA, Yag C. Mammography screening credit card and compliance. Cancer. 1992 Jul 15;70(2):509-12. PMID: 1617601.

19. Schapira DV, Kumar NB, Lyman GH. The Effect of Tamoxifen Therapy on Serum Cholesterol. JADA. 1991; 91:982.

20. Schapira DV, Kumar NB, Lyman G. Obesity, Body Fat Distribution and Sex Hormones in Breast Cancer Patients. The Digests. 1992; 29.

21. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-Body Fat distribution and Endometrial Cancer Risk. Obesity and Health. 1992; 24.

22. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA South American Edition. 1992; 266:82-6.

23. Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper-body fat distribution and endometrial cancer risk. JAMA Turkish Edition. 1992; 5:505-8.

24. Schapira DV, Pamies RJ, Kumar NB, Herold AH, Van Durme DJ, Woodward LJ, Roetzheim RG. Cancer screening. Knowledge, recommendations, and practices of physicians. Cancer. 1993 Feb 1;71(3):839-43. PMID: 8431866.

of 59


25. Schapira DV, Pamies RJ, Kumar NB, Herold AH, Van Durme DJ, Woodward LJ, Roetzheim RG. Cancer screening, knowledge, recommendations, and practices of physicians. Cancer (Residents and Fellows Edition). 1993; 1:31-5. PMID: 8431866.

26. Schapira DV, Kumar NB, Lyman GH. Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families. Cancer. 1993 May 1;71(9):2764-8. PMID: 8467456.

27. Kumar NB, Bostow DE, Schapira DV, Kritch KM. Efficacy of interactive, automated programmed instruction in nutrition education for cancer prevention. J Cancer Educ. 1993 Fall;8(3):203-11. PMID: 8274368.

28. Schapira D, Wolff P, Kumar N, Anderson J, Aziz N, Lyman G, Swanson M. The effect of weight-loss on estimated breast-cancer risk and sex-hormone levels. Oncol Rep. 1994 May;1(3):613-7. PMID: 21607413.

29. Schapira DV, Clark RA, Wolff PA, Jarrett AR, Kumar NB, Aziz NM. Visceral obesity and breast cancer risk. Cancer. 1994 Jul 15;74(2):632-9. PMID: 8033042.

30. Kumar NB, Lyman GH, Allen K, Cox CE, Schapira DV. Timing of weight gain and breast cancer risk. Cancer. 1995 Jul 15;76(2):243-9. PMID: 8625099.

31. Kumar NB, Allen K, Cantor A, Cox CE, Greenberg H, Shah S, Lyman GH. Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact? Breast Cancer Res Treat. 1997 Jun;44(2):135-43. PMID: 9232272.

32. Kumar NB, Besterman-Dahan K. Nutrients in the Chemoprevention of Prostate Cancer: Current and Future Prospects. Cancer Control. 1999 Nov;6(6):580-586. PMID: 10756389.

33. Kumar NB, Cantor A, Allen K, Cox CE. Android obesity at diagnosis and breast carcinoma survival: Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span, and survival from breast carcinoma. Cancer. 2000 Jun 15;88(12):2751-7. PMID: 10870057.

34. Burns PA, Kumar NB. Alternative and complementary nutritional therapies in cancer prevention and treatment: implications in clinical practice. Nutrition. 2001 Mar;17(3):274-5. PMID: 11312079.

35. Kumar NB, Dalton KB. Eicasapentaenoic acid: promising nutritional supplement in the treatment of cancer cachexia in elderly patients. JEBIM. 2001; 1:3.

of 59


36. Kumar NB, Cantor A, Allen K, Riccardi D, Cox CE. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer. 2002 Feb 15;94(4):1166-74. PMID: 11920488; PMCID: PMC2377415.

37. Kumar NB, Hopkins K, Allen K, Riccardi D, Besterman-Dahan K, Moyers S. Use of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice. Cancer Control. 2002 May-Jun;9(3):236-43. PMID: 12060821.

38. Kazi A, Daniel KG, Smith DM, Kumar NB, Dou QP. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol. 2003 Sep 15;66(6):965-76. PMID: 12963483.

39. Kazi A, Urbizu DA, Kuhn DJ, Acebo AL, Jackson ER, Greenfelder GP, Kumar NB, Dou QP. A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells. Int J Mol Med. 2003 Dec;12(6):879-87. PMID: 14612961.

40. Kumar N, Allen KA, Riccardi D, Bercu BB, Cantor A, Minton S, Balducci L, Jacobsen PB. Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit? Breast Cancer Res Treat. 2004 Jan;83(2):149-59. PMID: 14997046.

41. Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J, Helal M, Salup R, Pow-Sang J. The specific role of isoflavones in reducing prostate cancer risk. Prostate. 2004 May 1;59(2):141-7. PMID: 15042614.

42. Moyers SB, Kumar NB. Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev. 2004 May;62(5):204-11. Review. PMID: 15212320.

43. Kumar N, Allen K, Riccardi D, Kazi A, Heine J. Isoflavones in breast cancer chemoprevention: where do we go from here? Front Biosci. 2004 Sep 1;9:2927-34. Review. PMID: 15353326.

44. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, Folsom AR, Sellers TA. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):656-61. PMID: 15767346.

45. Kumar NB, Allen K, Bell H. Perioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening. Cancer Control. 2005 Jul;12(3):149-57. Review. PMID: 16062162.

46. Kumar NB, Riccardi D, Cantor A, Dalton K, Allen K. A case-control study evaluating the association of purposeful physical activity, body fat

of 59


distribution, and steroid hormones on premenopausal breast cancer risk. Breast J. 2005 Jul-Aug;11(4):266-72. PMID: 15982394.

47. Kumar NB. Green Tea Polyphenols (GT): Promising Substances for Prostate Cancer Chemoprevention. JEBIM. 2005; 2:1.

48. Allen KA, Bell H, Kumar NB. Herbal Supplements & Potential Risks for Surgical Patients. JEBIM. 2006; 2:3.

49. Park JY, Zheng W, Kim D, Cheng JQ, Kumar N, Ahmad N, Pow-Sang J. Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor. Cancer Detect Prev. 2007;31(5):359-65. Epub 2007 Nov 26. PMID: 18037591.

50. Kumar N, Shibata D, Helm J, Coppola D, Malafa M. Green tea polyphenols in the prevention of colon cancer. Front Biosci. 2007 Jan 1;12:2309-15. Review. PMID: 17127241.

51. Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R, Kang L, Xu P, Pow-Sang J. Safety of purified isoflavones in men with clinically localized prostate cancer. Nutr Cancer. 2007;59(2):169-75. PMID: 18001211; PMCID: PMC2442460.

52. Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, Salup R, Kang L, Xu P, Pow-Sang J. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer. Nutr Cancer. 2007;59(2):163-8. PMID: 18001210; PMCID: PMC2435485.

53. Deng GE, Cassileth BR, Cohen L, Gubili J, Johnstone PA, Kumar N, Vickers A; Society for Integrative Oncology Executive Committee, Abrams D, Rosenthal D, Sagar S, Tripathy D. Integrative Oncology Practice Guidelines. J Soc Integr Oncol. 2007 Spring;5(2):65-84. Review. PMID: 17511932.

54. Cassileth BR, Deng GE, Gomez JE, Johnstone PA, Kumar N, Vickers AJ; American College of Chest Physicians. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep;132(3 Suppl):340S-354S. PMID: 17873179.

55. Dahan K, Fennal M, Kumar NB. Lycopene in the prevention of prostate cancer. J Soc Integr Oncol. 2008 Winter;6(1):29-36. Review. PMID: 18302908.

56. Kumar NB, Besterman-Dahan K, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Krischer JP. Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. Clin Med Urol. 2008 Apr 16;1:1-14. PMID: 20354574; PMCID: PMC2846655.

of 59


57. Sellers TA, Vierkant RA, Djeu J, Celis E, Wang AH, Kumar N, Cerhan JR. Unpasteurized milk consumption and subsequent risk of cancer. Cancer Causes Control. 2008 Oct;19(8):805-11. doi: 10.1007/s10552-008-9143-8. Epub 2008 Mar 15. PMID: 18344007; PMCID: PMC2575230.

58. Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):341-5. doi: 10.1158/1055-9965.EPI-08-0819. PMID: 19124518; PMCID: PMC3156033.

59. Odedina FT, Akinremi TO, Chinegwundoh F, Roberts R, Yu D, Reams RR, Freedman ML, Rivers B, Green BL, Kumar N. Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S2. doi: 10.1186/1750-9378-4-S1-S2. PMID: 19208207; PMCID: PMC2638461.

60. Reams RR, Agrawal D, Davis MB, Yoder S, Odedina FT, Kumar N, Higginbotham JM, Akinremi T, Suther S, Soliman KF. Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: a pilot project study. Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S3. doi: 10.1186/1750-9378-4-S1-S3. PMID: 19208208; PMCID: PMC2638462.

61. Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, Courneya KS, Dryden T, Hanser S, Kumar N, Labriola D, Wardell DW, Sagar S; Society for Integrative Oncology. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009 Summer;7(3):85-120. PMID: 19706235.

62. Odedina FT, Yu D, Akinremi TO, Reams RR, Freedman ML, Kumar N. Prostate cancer cognitive-behavioral factors in a West African population. J Immigr Minor Health. 2009 Aug;11(4):258-67. doi: 10.1007/s10903-008-9212-9. Epub 2008 Dec 4. PMID: 19051034.

63. Kumar NB, Yu D, Akinremi TO, Odedina FT. Comparing dietary and other lifestyle factors among immigrant Nigerian men living in the US and indigenous men from Nigeria: potential implications for prostate cancer risk reduction. J Immigr Minor Health. 2009 Oct;11(5):391-9. doi: 10.1007/s10903-009-9231-1. Epub 2009 Feb 19. PMID: 19225888.

64. Kumar NB, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Besterman-Dahan K, Krischer JP. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy. J Soc Integr Oncol. 2010 Winter;8(1):3-13. PMID: 20205984; PMCID: PMC3277948.

65. Kumar NB, Kazi A, Smith T, Crocker T, Yu D, Reich RR, Reddy K, Hastings S, Exterman M, Balducci L, Dalton K, Bepler G. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment.

of 59


Curr Treat Options Oncol. 2010 Dec;11(3-4):107-17. doi: 10.1007/s11864-010-0127-z. Review. PMID: 21128029; PMCID: PMC3016925.

66. Brem S, Kumar NB. Management of treatment-related symptoms in patients with breast cancer. Clin J Oncol Nurs. 2011 Feb;15(1):63-71. doi: 10.1188/11.CJON.63-71. Review. PMID: 21278042.

67. Chornokur G, Dalton K, Borysova ME, Kumar NB. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate. 2011 Jun 15;71(9):985-97. doi: 10.1002/pros.21314. Epub 2010 Dec 28. Review. PMID: 21541975; PMCID: PMC3083484.

68. Galeb S, Reljic T, Djulbegovic B, Gwede C, Kumar NB, Kumar A. Are African American men adequately represented in prostate cancer randomized controlled trials?. J Clin Oncol. 2011 June; 29(Supp 6066).

69. Connors SK, Chornokur G, Kumar NB. New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer. Nutr Cancer. 2012;64(1):4-22. doi: 10.1080/01635581.2012.630158. Epub 2011 Nov 18. Review. PMID: 22098273; PMCID: PMC3665011.

70. Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Connors S, Chornukur G, Dickinson SI, Bai W, Williams CR, Salup R, Fu W. Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures. J Cancer Sci Ther. 2012;2011(S3). pii: 007. Epub 2012 Jan 10. PMID: 22422102; PMCID: PMC3300067.

71. Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Anderson K. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. J Clin Trials. 2012 Jan 21;2(1). pii: 1000105. PMID: 24533253; PMCID: PMC3924733.

72. Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012 Mar;33(2):279-85. doi: 10.1016/j.cct.2011.11.004. Epub 2011 Nov 11. PMID: 22101219; PMCID: PMC3268882.

73. Ribeiro MD, Silva AS, Bailey KM, Kumar NB, Sellers TA, Gatenby RA, Ibrahim-Hashim A, Gillies RJ. Buffer Therapy for Cancer. J Nutr Food Sci. 2012 Aug 15;2:6. PMID: 24371544; PMCID: PMC3872072.

74. Alexandrow MG, Song LJ, Altiok S, Gray J, Haura EB, Kumar NB. Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung

of 59


cancer. Eur J Cancer Prev. 2012 Sep;21(5):407-12. doi: 10.1097/CEJ.0b013e32834ef194. PMID: 22156994; PMCID: PMC3319490.

75. Kumar N, Chornokur G. Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention. Transl Med (Sunnyvale). 2012 Dec 31;Suppl 2:005. PMID: 24527269; PMCID: PMC3920581.

76. Kumar NB, Vadaparampil ST, Mahajan N, Lilienfeld HS, Lee J, Laronga C, Hakam A, Heine JJ, Egan, KM, Arun B, Pal T. Metformin – promising agent for chemoprevention in BRCA1 carriers. Hereditary Genetics. 2012; 1(2). PMID: 26097796. PMCID:PMC4474476.

77. Chornokur G, Amankwah EK, Davis SN, Phelan CM, Park JY, Pow-Sang J, Kumar NB. Variation in HNF1B and Obesity May Influence Prostate Cancer Risk in African American Men: A Pilot Study. Prostate Cancer. 2013;2013:384594. doi: 10.1155/2013/384594. Epub 2013 Dec 9. PMID: 24386569; PMCID: PMC3872424.

78. Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Daniel K, Deng G, Djeu J, Dou J, Hawk E, Jayaram B, Jia L, Joshi R, Kararala M, Karunagaran D, Kucuk O, Kumar L, Malafa M, Samathanam GJ, Sarkar F, Siddiqi M, Singh RP, Srivastava A, White JD. Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival. Cancer Med. 2013 Feb;2(1):108-15. PMID: 24279005; PMCID: PMC3797562.

79. Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, Pietanza MC, Cassileth BR. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e420S-36S. doi: 10.1378/chest.12-2364. PMID: 23649450.

80. Chornokur G, Kumar NB. Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research. Cancer Causes Control. 2013 Aug;24(8):1465-80. doi: 10.1007/s10552-013-0241-x. Epub 2013 Jun 5. Review. PMID: 23737026; PMCID: PMC4184029.

81. Green BL, Rivers DA, Kumar N, Baldwin J, Rivers BM, Sultan D, Jacobsen P, Gordon LE, Davis J, Roetzheim R. Establishing the infrastructure to comprehensively address cancer disparities: a model for transdisciplinary approaches. J Health Care Poor Underserved. 2013 Nov;24(4):1614-23. doi: 10.1353/hpu.2013.0186. PMID: 24185157; PMCID: PMC4163783.

82. Kim SJ, Amankwah E, Connors S, Park HY, Rincon M, Cornnell H, Chornokur G, Hashim AI, Choi J, Tsai YY, Engelman RW, Kumar N, Park JY. Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prev Res (Phila).

of 59


2014 Apr;7(4):435-44. doi: 10.1158/1940-6207.CAPR-13-0427-T. Epub 2014 Feb 5. PMID: 24501325; PMCID: PMC4123218.

83. Kumar NB , Quinn GP, Alexandrow MG, Gray J, Schell MJ, Sutton S, Haura, EB. Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer. J Clin Trials. 2014;4:180-6. doi:10.4172/2167-0870.1000180. PMCID: 26101725. PMCID:PMC4474484.

84. Handling EP, Small BJ, Reynolds SL, Kumar NB. Impact of Dietary Factors and Inflammation on Cogntion Among Older Adults. The journal of prevention of Alzheimer's disease. 2015;2(4):220-6. http://dx.dio.org/10.14283.jpad.2015.50.

85. Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber D, Sebti S, Kazi A, Lang L, Quinn G, Smith T, Diaz K, Chornokur G, Crocker T, Schell MJ. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prev Res (Phila). 2015;8(10):879-87. [Epub ahead of print] PMID: 258733370. PMCID: PMC4596745.

86. Block KI, Gyllenhaal C, Lowe L, Amedei A,A.R.M. Amin ARM, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Zhuo Chen G, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong J-T, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali DG, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu H-Y, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee H-Y, Lichtor T, Lin L-T, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muqbil I, Muralidhar V, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Vasantha Rupasinghe HP, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang

of 59

http://dx.dio.org/10.14283.jpad.2015.50


Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M. Designing a broad-spectrum integrative design for cancer prevention and therapy. Semin Cancer Biol. 2015;35(Suppl):S276-304. http://dx.doi.org/10.1016/j.semcancer.2015.09.007. PMID: 26590477. PMCID in Progress.

87. Mohammad RM, Muqbil I, Lowe L, Yedjour C, Hsu H-Y, Lin, LT, Siegelin MD, Fimognari C, Kumar NB, Dou QP, Yang H, Samadi AK, Russo GL, Spagnuolos C, Ray SK, Chakrabarti M, Morre JR, Coley HM, Honoki K, Fujii H, Geogakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich WG, Yang X, Boosani CS, Guha G, Bhakta D, Ciroilo MR, Aquailano K, Chen S, Mohammed SI, Keith WN, Bilsland A, Halicka D, Nowsheen S, Azmi AS. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 2015;35(Suppl):S78-S103. doi: 10.1016/j.semcancer.2015.03.001. Epub 2015 Apr 28. Review. PMID: 25936818.

88. Kumar NB , Pow-Sang J, Spiess PE, Park JY, Salup R, Williams CR, Parnes H, Schell M. Randomized, Placebo-controlled Trial Evaluating the Safety of One-Year Administration of Green Tea Catechins. Cancer Prevention Research. Submitted Dec 2015.

89. Leone A, Diorio G, Sexton W, Schell M, Alexandrow M, Kumar NB. Sulforaphane for the Chemoprevention of Bladder Cancer: Molecular Mechanism Targeted Approach. European Journal of Cancer Prevention. Submitted Feb 2016.

90. Kumar NB , Pow-Sang J, Spiess PE, Park JY, Chornokur G, Phelan C. Prostate Cancer Chemoprevention in African American Men: Promises & Challenges. Cancer Control Journal. Submitted Feb 2016.

Invited Publications

Books1. Schapira DV, Kumar NB. The Good Book of Nutrition. American Cancer

Society. Atlanta, GA. 1988. Co-Author

2. Schapira DV, Kumar NB, Lyman GH. Effective Duration of Intervention and Locus of

Control in Dietary Change. Yearbook of Family Practice. Mosby-Yearbook. St. Louis,

MO. 1992. Contributing author

3. Kumar NB, Moyers S, Schapira DV. Forkwise: Diet in the Prevention of Cancer. H. Lee Moffitt Cancer Center and Research Institute, Inc. & Research Center, Tampa, FL. 1998. Co-Author/Editor

4. Kumar NB, Moyers S, Allen K, Riccardi D, Besterman K. Integrative Nutritional

of 59

http://dx.doi.org/10.1016/j.semcancer.2015.09.007


Therapies in Cancer Treatment & Prevention. Facts & Comparisons, a division of Lippincott Williams & Wilkins Inc., A Wolters Kluwer Company. St. Louis, MO. 2002. Senior Author.

5. Kumar NB. Nutritional Management of Symptoms of Cancer Treatment Effects.

ISBN 978-3-642-27232-5 e-ISBN 978-3-642-27233-2. DOI 10.1007/978-3-642-27233-2

Springer Heidelberg, Dordrecht, London, New York. 2012. Author/Editor

Book Chapters1. Kumar NB. Introduction to Cancer: Oncology Principles and Management.

(Chapter 1, pp1-11) Best Practices in Oncology Management: Focus on Swallowing Disorders. Singular Publishing Group, Inc., San Diego, CA. 1997.

2. Kumar NB, Hudson J, Crocker T, Riccardi D, Allen K. Nutrition, Cancer &

the Aging Process: A Rationale for Nutritional Practice Guidelines. Comprehensive

Geriatric Oncology (2nd edition). Balducci L, Lyman GH, Ersher WB, Extermann M

(Eds). Harwood Academic Publishers, London. 2002.

3. Myers CD, Kumar N, Craig DS, Strozier A. Complementary and Alternative Medicine

(CAM). In Markides KS (Ed.), Encyclopedia of Health & Aging. Sage Publications. Thousand Oaks, CA. 2006.

4. Kumar N, Besterman-Dahan K, Kazi A, Heine J. Isoflavones in Breast Cancer

Chemoprevention. Herbal Drugs: A Twenty First Century Perspective, 2nd Edition.

Sharma RK and Arora R (Eds.). Jaypee Brothers Medical Publishers Pvt. Ltd,

Delhi, India. 2009.

5. Chornokur G, Kumar N. Green tea catechins and prostate carcinogenesis. In Phytochemicals - Isolation, Characterisation and Role in Human Health. Edited by A. Venket Rao and Leticia G. Rao. InTech Publishing. Croatia. 2015. ISBN 978-953-51-2170-1. http://www.intechopen.com/articles/show/title/green-tea-catechins-for-prostate-cancer-chemoprevention

Technical Reports and Published Book Reviews

1. Kumar NB , National Comprehensive Cancer Center Network (NCCN) Nutritional

of 59

http://www.intechopen.com/articles/show/title/green-tea-catechins-for-prostate-cancer-chemoprevention

http://www.intechopen.com/articles/show/title/green-tea-catechins-for-prostate-cancer-chemoprevention


Symptom Management Guidelines, Preliminary Technical Report. 2004.

2. Kumar NB . Panel Member/Presenter. The promises and perils of lycopene/tomato

supplementation and cancer prevention. Session IV: What have we learned from

Clinical Trials? NIH/NCI/NCCAM/ODS/FDA. Executive Summary, the Journal of

Clinical Nutrition. 2005;135:8.

3. Deng GE, Cassileth BR, Gubili J, Johnstone P, Kumar N, Vickers A. Diagnosis and

Management of Lung Cancer: American College of Chest Physicians: Evidence-Based

Guidelines for Integrative medicine (2nd Edition), Health and Science Policy Committee.

2006-2007.

4. Deng G, Jones L, Kumar NB, Pietanza M, Sagar S, Yeung S. A. Diagnosis and

Management of Lung Cancer: American College of Chest Physicians: Health & Science

Policy (HSP) Integrative Oncology chapter of the Lung Cancer guidelines (3rd

Edition), Health and Science Policy Committee. 2012.

Other Research and Creative Works

Electronic Publications:1. Development of Educational Software: WHISSL Project. (PI: Rodger Marion, UTMB)

Role: Collaborating Faculty in Clinical Nutrition. Collaborated in the development of the Worldwide Health Information System Simulation Linkage (WHISSL, http://whissl.utmb.edu) has been an on-going project at the University of Texas Medical Branch (UTMB). The current focus of the WHISSL is developing patient cases with cultural components, and designing and testing web-based programming tools for use by Medical student education. Since 1991.

2. Kumar NB. Automated Programmed Instruction on Diet & Cancer Prevention, Environmental Design Planners, Inc., Florida. 1993.

3. Kumar NB. Alternative and Complementary/Integrative Nutritional Therapies in Cancer Treatment & Prevention. Moffitt Cancer Network (MCN), H. Lee H. Lee Moffitt Cancer Center and Research Institute, Inc. & Research Center, Tampa, FL. 2000 July.

Other creative published works:

of 59


1. Kumar NB. Introduction to Prostate Cancer in African Americans, Disparities in Incidence and Mortality & Morbidity, Etiology & Implications Disparities In Prostate Cancer Incidence & Survival in African Americans. A PC based Education Module for The FAMU Center for Minority Prostate Cancer Training and Research (FAMU MPC Center) in partnership with the H. Lee Moffitt Cancer Center and Research Institute, Inc. & Research Institute. 2005.

2. Kumar NB. Lifestyle Factors and Prostate Cancer Prevention. A PC based Education

Module for The FAMU Center for Minority Prostate Cancer Training and Research (FAMU MPC Center) in partnership with the H. Lee Moffitt Cancer Center and Research Institute, Inc. & Research Institute. 2005.

3. Kumar NB, Odedina F. 10 Practical Guidelines to develop and sustain successful

scientific collaborations. Department of Defense (DOD) Breast Cancer Research Program (BCRP) Era of Hope 2008 Meeting. June 2008.

Scientific Abstracts/Poster Presentations/Plenary Presentations

1. Grand RoundsKumar NB. Nutrients in Cancer Chemoprevention. Parrish Affiliates, Parrish Medicine Center; 2002 October 16; Parrish, FL, USA.

Kumar NB. Nutrients in Prostate Cancer Chemoprevention. Moffitt Affiliates Sponsored Program, Manatee Memorial Hospital; 2003 January 16; Bradenton, FL, USA.

Kumar NB. Nutrients in Prostate Cancer Chemoprevention. Cox Health Care Systems, Research Grand Rounds Springhill Medical Association; 2003 January 30; Springhill, MO, USA.

Kumar NB. Nutrients in Cancer Chemoprevention. Leesburg Regional Medical Center; 2004 March 24; Leesburg, FL, USA. Kumar NB. Nutrition, Physical Activity, Broad fat distribution, Steroid Hormones and Breast Cancer. University of West Indies Cancer Center; 2004 August 10; Kingston, Jamaica.

Kumar NB. Florida A & M University, Center for Minority Prostate Cancer Training and Research: A collaborative program between FAMU and H. Lee Moffitt Cancer Center and Research Institute, Inc., PC030462-Department of Defense. H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2004 September 24; Tampa, FL, USA.

Kumar NB. Nutrients in Cancer Chemoprevention. St. Joseph's / Candler Community Hospital; 2004 October 06; Savannah, GA, USA.

of 59


Kumar NB. Nutrients & Nutrient Derived Agents for Cancer Chemoprevention. Howard University; 2005 April 26; Washington, DC, USA.

Kumar NB. Integrative Medicine: Scientific approach to evaluating nutrients as chemopreventive agents. Department of Interdisciplinary Oncology Clinical Grand Rounds, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2005 August 05; Tampa, FL, USA.

Kumar NB. Herbal & Nutritional Supplements in Health and Disease Prevention - Fact or Fiction. H. Lee Moffitt Cancer Center and Research Institute, Inc., Department of Interdisciplinary Oncology; 2005 November 11; Tampa, FL, USA.

Kumar NB. Nutrition, Lifestyle Factors in Cancer and other Disease Prevention. Regional Medical Center; 2007 April 19; Ocala, FL, USA.

Kumar NB. Nutrients in Chemoprevention - Challenges and Promises. GRIPS - Grand Rounds in Population Science, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2008 January 24; Tampa, FL, USA.

Kumar NB. Nutrients in Cancer Chemoprevention - Challenges and Promises. Baptist Hospital; 2008 June 13; Pensacola, FL, USA.

Kumar N. The Role of Nutrients in Cancer Chemoprevention. All Children's Hospital; 2009 July; St. Petersburg, FL, USA.

Kumar NB. The role of nutrients in cancer chemoprevention. Leesburg Regional Hospital, Central Florida Health Alliance; 2010 June; Leesburg, FL, USA.

Kumar NB. Nutrients and nutrient-derived substances in Cancer Chemoprevention. All Children's Hospital Pediatrics, University of South Florida, College of Medicine; 2010 July 10; Tampa, FL, USA.

Kumar N. The Role of Nutrients in Cancer Chemoprevention, Treatment and Survival. Bethesda Comprehensive Cancer Center; 2011 April; West Palm Beach, FL, USA.

Kumar N. Nutrition, Aging and Cancer: Can you turn back the clock? Grand Rounds Doc Talk, Leesburg Regional Hospital, Central Florida Health Alliance; 2011 July 13; Leesburg, FL, USA.

Kumar NB. Systematic Approach in the Development of Botanicals and Biologics for Cancer Prevention and Treatment. Cancer Medicine Grand Rounds - M.D. Anderson Cancer Center; 2012 January 17; Houston, TX, USA.

Kumar NB. Systematic Approach in the Development of Botanicals and Biologics for Cancer Prevention and Treatment. Integrative Medicine Grand Rounds - M.D. Anderson Cancer Center; 2012 January 17; Houston, TX, USA.

Kumar NB. Botanicals and Biologics in Cancer Chemoprevention, Treatment and Survival. Parrish Medical Center; 2012 November; Parrish, FL, USA.

of 59


Kumar NB. Systematic Approach in Evaluating Botanicals for Cancer Prevention. Grand Rounds - Carcinogenesis and Chemoprevention Lecture - The James Comprehensive Cancer Center, Ohio State University; 2013 September 26; Columbus, OH, USA.

Kumar NB. Nutritional Management of Cancer treatment Effects. Ponce School of Medicine and Health Sciences; 2015; January 28; Puerto RicoKumar N. Cancer Interception: Systematic Approach in Evaluating Agents for Clinical Cancer Prevention. M. D. Anderson; 2015; July 23 – 24; Houston, TX, USA

Kumar NB. Interventions to treat neurocognitive deficits and other treatment-related adverse effects in survivors of childhood cancers. St. Judes’ Children’s Hospital; 2015 July 27 – 28; Memphis, TN, USA

Kumar NB. Systematic Approach to Evaluating Botanicals for Cancer Chemoprevention. Sri Ramachandra University, College of Medicine; 2015; October 8; Chennai, India

2. InvitedKumar NB. Research in Cancer Prevention. Sarasota Dietetic Association; 1987 November; Sarasota, FL, USA.

Kumar NB. Diet & Cancer: The Good Book of Nutrition. Channel 10, an ABC Affiliate; 1988 February; St. Petersburg, FL, USA.

Kumar NB. Psychogenic Factors in Breast Disease: A Graduate Thesis in Behavioral Medicine. Public Broadcast System - WEDU-TV; 1988 April; Tampa, FL, USA.

Kumar NB. Diet and Behavior Modification for Cancer Prevention. Behavioral Medicine Doctoral Class, University of South Florida; 1988 April; Tampa, FL, USA.

Kumar NB. Psychogenic Factors in Breast Disease: A Graduate Thesis in Behavioral Medicine. University of South Florida Psychosocial Medicine Conference; 1988 May; Tampa, FL, USA.

Kumar NB. Diet and Cancer: Quality Cancer Care in the Community. Oncology Nursing Association; 1990 March; Tampa, FL, USA.

Kumar NB. Nutritional Impact of Cancer. Oncology Nursing Association; 1991 March; Tampa, FL, USA.

Kumar NB. Weight Gain Associated with Tamoxifen: Fact or Artifact? 17th Annual Nicholas J. Thompson Cancer Update, Wayne State University Medical Center; 1997 April; Dayton, OH, USA.

Kumar NB. Weight Gain in Breast Cancer Patients on Chemotherapy: Exploring Hormonal, Body Composition and Behavioral Mechanisms. Cancer Control

of 59


Research Interest Group, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 1998 October; Tampa, FL, USA.

Kumar NB. The Specific Role of Genistein in Reducing Hormonal and Proliferative Markers that are implicated in Prostate Cancer. Cancer Research Interest Group, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 1999 June 17; Tampa, FL, USA.

Kumar NB. Alternative Nutritional Therapies: What to Tell Your Patient? Cancer Communications: Talk, Tools & Technology, CPEN; 1999 September 23; Tampa, FL, USA.

Kumar NB. The Specific Role of Genistein in Estrogen Metabolism. H. Lee Moffitt Cancer Center and Research Institute, Inc. Clinical Grand Rounds; 2000 January; Tampa, FL, USA.

Kumar NB, Riccardi D, Allen K, Cantor A, Jacobsen P, Horton J, Minton S, Balducci L, Lyman GH. Weight Gain in Breast Cancer Patients on Chemotherapy: Exploring Hormonal, Body Composition and Behavioral Mechanisms. U. S. Army Breast Cancer Research Program - Era of Hope; 2000; Atlanta, GA, USA. Kumar NB. Stuck in the middle with you: Android Obesity and Disease Risk in Women. Speaking of Women's Health; 2000 September; Tampa, FL, USA.

Kumar NB. Nutrients in Chemoprevention: Current and Future Research Studies. Cancer Control Research Interest Group, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2000 November 09; Tampa, FL, USA.

Kumar NB. Diet & Cancer Prevention. 21st Annual Nicholas J. Thompson Cancer Update, Wright State University Medical Center; 2001 April; Dayton, OH, USA.

Kumar NB. Nutrients in Chemoprevention. 21st Annual Nicholas J. Thompson Cancer Update, Wright State University Medical Center; 2001 April; Dayton, OH, USA.

Kumar NB. Nutritional Considerations in the Cancer Patient & Cancer Prevention. Oncology Nursing Graduate Nursing Students, University of South Florida, College of Nursing; 2002 September 06; Tampa, FL, USA.

Kumar NB. Complementary Alternative Medicine. Department of Obstetrics/Gynecology, University of South Florida, College of Medicine; 2002 November 13; Tampa, FL, USA.

Kumar NB. Cancer Prevention. Surgical Residents Lecture Series, University of South Florida, College of Medicine; 2002 December 02; Tampa, FL, USA.

Kumar NB. Palliative Care Lecture - Nutrition & the Cancer Patient. H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2002 December 11; Tampa, FL, USA.

of 59


Kumar NB. Complementary Alternative Medicine. Alternative Medicine Colloquium, 3rd Year Medical Students Seminar, University of South Florida, College of Medicine; 2003 January 13; Tampa, FL, USA.

Kumar NB. Nutrients in Cancer Chemoprevention. Cox Health Care Systems, Springhill Medical Association; 2003 January 30; Springhill, MO, USA.

Kumar NB. Nutrients in Cancer Chemoprevention. Institute on Aging Lecture, University of South Florida, College of Public Health, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2003 February 12; Tampa, FL, USA.

Kumar NB . Nutrients in Cancer Chemoprevention. Skill Building in Psychosocial Oncology & Palliative Care Conference, Palliative Care Program, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2003 March 28; Tampa, FL, USA.

Kumar NB. Nutritional Guidelines for Health & Disease. 1st Year Medical Students Seminars University of South Florida, College of Medicine; 2003 October 05; Tampa, FL, USA.

Kumar NB. Complementary Alternative Medicine. Alternative medicine colloquium, 3rd Year Medical Students Seminar, University of South Florida, College of Medicine; 2004 January 13; Tampa, FL, USA.

Kumar NB. Nutrition and lifestyle factors for cancer prevention: focus on African Americans. African American Health Forum, Hillsborough Community College; 2004 March 06; Tampa, FL, USA.

Kumar NB. Nutrition & Cancer. Public Broadcast System - WEDU-TV; 2004 August 05; Tampa, FL, USA.

Kumar NB. Diet, Physical Activity & Cancer Prevention: Focus on African Americans. African American Men's Health Forum, Florida A & M University; 2004 September 18; Tallahassee, FL, USA.

Kumar NB. Nutrition and Cancer Prevention. St. Joseph's/Candler Community Health Forum - Marsh Auditorium; 2004 October 05; Savannah, GA, USA.

Kumar NB. Nutrients & Nutrient Derived Agents in Cancer Chemoprevention. Grand Opening - Integrative Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2005 February 22; Tampa, FL, USA.

Kumar NB. Skill Building Workshop. Psychosocial Oncology and Palliative Care, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2005 March 11; Tampa, FL, USA.

Kumar NB. Why is Nutrition Critical in the Elderly? Integrative Nutritional Therapies for Cancer Symposium for Journalist, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2005 March 29; Tampa, FL, USA.

of 59


Kumar NB. Report of the Collaborative Partnership between Florida A & M University and the H. Lee Moffitt Cancer Center and Research Institute, Inc., Department of Defense. 2005 July 25; Tallahassee, FL, USA.

Kumar NB. Nutrients and Cancer Prevention: Focus on Women. FACTORS, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2005 September 17; Tampa, FL, USA.

Kumar NB. Nutrition and Cancer: Focus on Women. The University of South Florida Women's Club; 2006 February 19; Tampa, FL, USA.

Kumar NB. Recruitment and Retention in Clinical Trials - Course: Cultural Influences and Diversity Issues in Clinical Research. University of South Florida, College of Public Health and College of Medicine; 2006 August 10; Tampa, FL, USA.

Kumar NB. Physical Activity and Cancer Prevention. H. Lee Moffitt Cancer Center and Research Institute, Inc. and University of South Florida, College of Medicine, Oncology Clerkship - 4th year Medical Students; 2006 August 31; Tampa, FL, USA.

Kumar NB. Integrative Medicine: Scientific approach to evaluating nutrients as chemopreventive agents. University of South Florida, College of Medicine; 2006 September 28; Tampa, FL, USA.

Kumar NB. Training the Next Generation. Project Inspire - HBCU Undergraduate Collaborative Summer Training Program to Inspire Students in Prostate Cancer Research. U. S. Department of Defense - the Innovative Minds in Prostate Cancer Today, IMPaCT Meeting; 2007 September 05; Atlanta, GA, USA.

Kumar N, Meade C, Jacobsen P, Gwede C, Odedina FO. Project INPSIRE-HBCU Undergraduate Collaborative Summer Training Program to Inspire Students in Prostate Cancer Research. U. S. Department of Defense - Innovative Minds in Prostate Cancer Today - IMPaCT Meeting; 2007 September 05; Atlanta, GA, USA.

Kumar NB. Nutrition & Cancer Research Studies. Sarasota - Urology Physician Affiliates; 2008 March 29; Sarasota, FL, USA.

Kumar NB. Chemoprevention Trials in Prostate Cancer. University of Florida Urology Group; 2008 May 09; Tampa, FL, USA.

Kumar NB. Disparity in Prostate Cancer - Research Initiatives. Delegation from Nigeria to H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2008 May 09; Tampa, FL, USA.

Kumar NB, Odedina FT. Develop and Maximize Effective Collaborations. U. S. Department of Defense, Breast Cancer Research Program (BCRP) - Era of Hope Meeting; 2008 June.

of 59


Kumar NB. Florida A & M University (FAMU) Center for Minority Prostate Cancer Training and Research: A Collaborative Program between FAMU and the H. Lee Moffitt Cancer Center and Research Institute, Inc., PC030462- U. S. Department of Defense. Florida A & M University Biennial Cancer Congress; 2008 June 19; Tallahassee, FL, USA.

Kumar NB. Chemoprevention Trials in Prostate Cancer. H. Lee Moffitt Cancer Center and Research Institute, Inc., University of Florida; 2008 June 23; Tampa, FL, USA.

Kumar NB. Invited Presentation: Nutrients in Chemoprevention: Promises and Challenges. University of Alabama at Birmingham, Comprehensive Cancer Center, Cancer Control and Population Sciences Program Quarterly Seminar; 2008 September 05; Birmingham, AL, USA.

Kumar NB. Pathobiology of Neoplasia about Nutrition and Cancer. University of South Florida, College of Nursing; 2008 September 09; Tampa, FL, USA.

Kumar NB. Chemoprevention. Sarasota Professional Partners; 2008 December 09; Sarasota, FL, USA. Kumar NB. Chemoprevention. 4th Annual GU Symposium, University of South Florida, College of Medicine; 2009 January 16; Tampa, FL, USA.

Kumar NB. Nutrients as Chemoprevention Agents. Moffitt Scientific Retreat; 2009 March 06; Tampa, FL, USA.

Kumar NB. Eliminating Disparities in Clinical Trials/EDICTS. H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2009 May 19; Tampa, FL, USA.

Kumar N. Botanicals and Cancer Research. National Institute of Cancer - Clinical Trials Workshop; 2009 July; Bethesda, MD, USA.

Kumar N. The Role of Nutrients in Cancer Chemoprevention. University of Tampa; 2009 September; Tampa, FL, USA.

Chornokur G, Lin HY, Park J, Phelan C, Kumar NB. Comprehensive population-specific bio-behavioral marker panel for early prostate cancer diagnostics and risk assessment: a DETECT study. The H. Lee Moffitt Cancer Center and Research Institute Inc., Scientific Retreat; 2010 March; Tampa, FL, USA.

Kumar NB. Drug - Nutrients/supplement interactions: Implications in Practice. Pain Medicine Lecture Series, University of South Florida, College of Medicine; 2010 June; Tampa, FL, USA.

Chornokur G, Park J, Kumar NB. Comprehensive population-specific bio-behavioral marker panel for early prostate cancer diagnostics and risk assessment: a DETECT study. Research in progress seminar at H. Lee Moffitt Cancer Center and Research Institute, Inc. and University of South Florida, College of Medicine; 2010 July; Tampa, FL, USA.

of 59


Kumar N. Systematic Approach to Cancer Chemoprevention. Frontiers in Carcinogenesis and Cancer Prevention International Conference; 2011 February 16; Bangalore, India.

Connors SK, Kumar NB. A cumulative molecular model for the mechanism of green tea catechins in the chemoprevention of prostate cancer. H. Lee Moffitt Cancer Center and Research Institute, Inc., Scientific Symposium; 2011 March 31; Tampa, FL, USA.

Kumar NB. The role of nutrients in cancer chemoprevention, treatment and survival. Integrative Medicine Seminar Series, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2011 May 05; Tampa, FL, USA.

Kumar NB. Systematic Approach to Cancer Chemoprevention. National Cancer Institute (NCI) / Indo-US Cooperation in Life Sciences Advisory Board (Cancer Botanical Drug Development); 2011 June 27; Rockville, MD, USA.

Kumar NB. Current research in nutrition and cancer. Tampa Rotary; 2011 August 05; Tampa, FL, USA.

Srivastava A, Darbari H, Badwe RA, Courtney P, Kumar A, Kumar NB, Lyerly HK, Mehta S, Srivastava R. Indo - U.S. - Cancer Collaboration: A VIVO Pilot. National Institute of Health (NIH); 2011 August 24; Washington, D.C., USA.

Kumar NB. Evaluation of botanical compounds in the prevention of prostate cancer. Florida Urologic Society; 2011 September 02; Naples, FL, USA.

Kumar NB. Nutrition and Cancer. University of South Florida, College of Nursing; 2011 September 12; Tampa, FL, USA.

Kumar NB. Nutrition and Cancer Prevention. Shumaker, Loop & Kendrick, LLP; 2011 October 18; Tampa, FL, USA.

Kumar NB, Kazi A, Smith T, Crocker T, Yu D, Reich RR, Reddy K, Hastings S, Exterman M, Balducci L, Dalton K, Bepler G. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. American Association of Cancer Research (AACR) Procedures and New Horizons in Cancer Research; 2011 December 13; Delhi, India.

Alexandrow MG, Song LJ, Aktiok S, Gray J, Haura EB, Kumar NB. Curcumin: A Novel Stat 3 Pathway Inhibitor for Chemoprevention of Lung Cancer. American Association of Cancer Research (AACR) Procedures and New Horizons in Cancer Research; 2011 December 13; Delhi, India.

Kumar NB, Dharandhar M, Jayaram B, Srivastava A. Indo-US partnership to accelerate botanicals and biologics drug development for cancer chemoprevention: In silico drug development model. American Association of Cancer Research (AACR) Procedures and New Horizons in Cancer Research; 2011 December 13; Delhi, India.

of 59


Kumar NB. Nutritional Implications and Management of Cancer Pain. Pain Medicine Lecture Series, University of South Florida, College of Medicine; 2012 March 06; Tampa, FL, USA.

Kumar NB. P5 plan to prevent prostate cancer. Man to Man Support Group. Watson Clinic; 2012 May 16; Lakeland, FL, USA.

Kumar NB, Quinn GP, Crocker T, Alexandrow M, Gray J, Estrella T, Schell M, Sutton S, Haura E. Assessment of feasibility and willingness of former heavy smokers to participate in chemoprevention trials to prevent lung cancer. National Cancer Institute (NCI) / American Society of Clinical Oncology (ASCO) Global Cancer Research; 2012 June 04; Chicago, IL, USA.

Kumar NB. P5 plan to prevent prostate cancer. Seminar series at the Moffitt International Plaza; 2012 June 14; Tampa, FL, USA.

Kumar NB. Nutritional Impact and Management of Chemosensory Dysfunction. National Comprehensive Cancer Network (NCCN) Nursing Program: Advancing Oncology Nursing; 2013 March 13; Hollywood, FL, USA.

Kumar NB. National Implications and Management of Pain. Pain Lecture Series, University of South Florida, Morsani College of Medicine; 2013 April; Tampa, FL, USA.

Kumar NB. The role of vitamins and supplements in the prevention and treatment of cancer. TeleTalk, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2013 April 15; Tampa, FL, USA.

Kumar NB. 10 things you can do to prevent cancer. Sneham Lecture Series - New Tampa Regional Library; 2013 June 01; Tampa, FL, USA.

Kumar NB. Live Webinar - National Impact and Management of Chemosensory Dysfunction. National Comprehensive Cancer Network (NCCN) Nursing Program: Advancing Oncology Nursing; 2013 June 06.

Kumar NB. Nutritional management of cancer and symptoms of cancer. Cancer Prevention - Pathobiology of Neoplasia, University of South Florida, College of Nursing; 2013 September 16; Tampa, FL, USA.

Kumar NB. Vitamin E3 for prostate cancer prevention in men post-prostatectomy. Malaysian Palm Oil Board; 2013 October 28; Tampa, FL, USA.

Kumar NB. Cognutrin - A pilot clinical trial of botanicals and biologics to ameliorate chemobrain. TeleTalk, H. Lee Moffitt Cancer Center and Research Institute, Inc.; 2013 November 05; Tampa, FL, USA.

Kumar NB. Cancer chemoprevention with botanicals targeting men with high risk for prostate cancer: research model for trial design and biomarker evaluation. Indian Institute of Technology; 2013 December 21; Chennai, India.

of 59


Kumar NB. Cancer Chemoprevention with Botanicals Targeting Men with High Risk for Prostate Cancer: Research Model for Trial Design and Biomarker Evaluation. Indian Institute of Technology; 2013 December 23; Chennai, India.

Kumar NB. Cancer Chemoprevention with Botanicals Targeting Men with High Risk for Prostate Cancer: Research Model for Trial Design and Biomarker Evaluation. Sri Ramachandra College of Medicine; 2013 December 24; Chennai, India.

Kumar NB. Human Research Protection: Navigating the Currents of Contemporary Research. Schulman Associates, IRB; 2014 April 10; Ft. Lauderdale, FL, USA.

Kumar NB. Nutritional implications and management of pain. University of South Florida, Department of Anesthesiology, Morsani College of Medicine; 2014 April 15; Tampa, FL, USA.

Kumar NB. Nutrition, physical activity and cancer prevention. Regency Oaks; 2014 April 30; Clearwater, FL, USA.

Kumar NB. Plant food for healing and health. TeleTalk, H. Lee Moffitt Cancer Center and Research Institute, Inc. and Research Institute, Inc.; 2014 July 29; Tampa, FL, USA.

Kumar NB. Research issues in cancer control. University of South Florida, College of Nursing; 2014 September 09; Tampa, FL, USA.

Kumar NB. Nutrition and the cancer patient. Pathophysiology of Neoplasia, University of South Florida, College of Nursing; 2014 September 15; Tampa, FL, USA.

Kumar NB. African Americans: Why should you participate in clinical trials? 50 Hoops/ National Physician and Family Referral (NPFR) Project; 2014 September 27; Tampa, FL, USA.

Kumar NB. The development of International Consortium for Chinese Medicine and Cancer. Panelist/Speaker - National Institute of Health (NIH) /National Cancer Institutes (NCI); 2014 November 03; Bethesda, MD, USA.

3. KeynoteKumar NB. Obesity and Breast Cancer (Keynote Speaker). 17th Annual Nicholas J. Thomas Cancer Update, Wright State University Medical Center; 1997 April; Dayton, OH, USA.

Kumar N. Nutrition and disease prevention. Annual Medical Expo Gala Dinner, Space Coast Medical Association; 2011 April 30; Melbourne, FL, USA.

4. Panel Participation

of 59


Kumar NB. Collaborative Partnership Panel. Department of Defense - The Innovative Minds in Prostate Cancer Today, IMPaCT Meeting; 2007 September 05; Atlanta, GA, USA.

Kumar NB. HBCU Collaborative Partnership Award (CPA). Department of Defense - The Innovative Minds in Prostate Cancer Today - IMPaCT Meeting; 2007 September 05; Atlanta, GA, USA.

Kumar NB. Green Tea Polyphenols and Polyphenon E as Proteasome Inhibitors. Polyphenon E - Mechanism of Action Expert Panel, Mitsui Norin, Inc. (Japan); 2007 April 26; Newark, NJ, USA.

Kumar NB. Systematic Approach to Cancer Chemoprevention. National Cancer Institute (NCI) / China - U.S. Cancer Symposium Panel on Traditional Chinese Medicine; 2011 July 08; Beijing, China.

Kumar NB. Grant Writing in Challenging Times. HERI; 2013 September 20; Tampa, FL, USA.

Kumar NB. Health & Fitness: Dare to be committed. 2014 University of South Florida Women in Leadership & Philanthropy Symposium; 2014 October 17; Tampa, FL, USA.

5. Plenary SessionsKumar NB. The Specific Role of Isoflavones in Reducing Prostate Cancer Risk. Session 7: Phytoestrogens and Antioxidants - What Have We Learned From Clinical Trials? 1st International Conference on the Society for Integrative Oncology; 2004 November; New York, NY, USA.

Kumar NB. A Randomized Pilot Clinical Trail of the Action (Independent Effects) of Isoflavones and Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. Session 4: The promises and perils of lycopene/tomato supplementation and cancer prevention workshop. National Institutes of Health/National Cancer Institute; 2005 February; Bethesda, MD, USA

Kumar NB. The promises and perils of lycopene/tomato supplementation and cancer prevention. Session 4: What Have We Learned from Clinical Trials? NIH/ NCI/ NCCAM/ ODS/ FDA; 2005 August; Washington, D.C., USA

Kumar NB. A case-control study evaluating the association of purposeful physical activity, body fat distribution and steroid hormones on pre-menopausal breast cancer risk. Session: Risk and Prevention: Prevention (Final Publication Number 4030). 28th Annual San Antonio Breast Cancer Symposium; 2005 December 08; San Antonio, TX, USA.

Kumar NB. Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: Is subclinical hypothyroidism the culprit? Session: Treatment: Patient Management (Final Publication Number 6057). 28th Annual San Antonio Breast cancer Symposium; 2005 December 08; San Antonio, TX, USA.

of 59


Kumar NB. Mixed Cancers - Novel Perspectives on Cancer Prevention and Control across Diverse Diagnosis: Botanical STAT-3 and NF-kB inhibitors for Lung Cancer Prevention: A promising look ahead. 9th International Conference of the Society of Integrative Oncology; 2012 October; Albuquerque, NM, USA

6. Poster PresentationConnors SK, Kumar NB. A Cumulative Molecular Model for the Mechanism of Green Tea Catechins in the Chemoprevention of Prostate Cancer. Center to Reduce Cancer Health Disparities (CRCHD) Program Meeting; 2011 July 12; Rockville, MD, USA.

Connors S, Kumar NB. A Cumulative Molecular Model for the Mechanisms of Green Tea Catechins in the Chemoprevention of Prostate. American Association of Cancer Research (AACR) Annual Meeting (Updated); 2012 March 31; Chicago, IL, USA.

Chornokur G, Amankwah EK, Park JY, Phelan CM, Kumar NB. Polymorphisms in the metabolism related genes and obesity may explain prostate cancer disparity in African American men. National Institute of Health (NIH) Science of Eliminating Health Disparities Summit; 2012 December.

Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn G, Smith R, Yue B, Diaz K, Chornokur G, Crocker T, Schell MJ. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Proceedings of the American Society of Clinical Oncology, 2015 June; Chicago, IL, USA.

Kumar NB, McCrary K, Quinn GP. G-WISE: A proposal using a novel approach – Calling on

Grandmother’s wisdom for recruitment and retention of African American men in prostate cancer clinical trials. 2015 Florida Alliance Scholars Program. 2015 July.

7. PresentationsSchapira DV, Kumar NB, McMillan S, Lyman G. Public Awareness of Food Labeling. Food and Society; 1988.

Schapira DV, Kumar NB, Lyman G, Cox C. Body Fat Distribution and Breast Cancer Risk. 11th Annual Breast Cancer Symposium; 1988.

Schapira DV, Kumar N, Lyman G, Cox C. Body Fat Distribution and Breast Cancer Risk. American Society of Clinical Psychology; 1989. Kumar NB. Diet & Cancer Prevention. American Cancer Society Conference for Family Practice Physicians; 1989 October; Tampa, FL, USA

Schapira DV, Kumar NB, Lyman GH, Cox CE. Body Fat Distribution and Breast Cancer Risk. Obstetrics/Gynecology Digest; 1990. Schapira DV, Kumar NB, Lyman GH, Cox C. Effect of Body Fat Distribution and Obesity in Breast Cancer Prognosis. Breast Cancer Research and Treatment; 1990.

of 59


Kumar NB. Anthropometry and Nutritional Assessments. Tampa Dietetic Association; 1990 April; Tampa, FL, USA

Schapira DV, Kumar NB, Clark RA, Yag C. Mammography Screening Credit Card and Compliance, American Association of Cancer Education; 1991

Kumar NB, Schapira DV, Lyman GH. Estimated Breast Cancer Risk Reduction with Weight Loss: Implications in Dietetic Practice. Annual Meeting of the American Dietetic Association; 1991; Orlando, FL, USA

Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts W, , LaPolla J. Abdominal Obesity and Endometrial Cancer Risk. American Society of Clinical Oncology; 1991

Schapira DV, Kumar NB, Lyman GH. Obesity, Body Fat Distribution, and Sex Hormones in Breast Cancer Patients. American Society of Clinical Oncology; 1991.

Schapira DV, Kumar NB, Lyman GH. Obesity, Body Fat Distribution, and Sex Hormones in Breast Cancer Patients. Current Opinion in Oncology; 1992.

Schapira DV, Kumar NB, Lyman GH, Cox CE. Obesity and Body Fat Distribution and Breast Cancer Prognosis. Current Opinion in Obstetrics and Gynecology; 1992.

Schapira DV, Kumar NB, Lyman GH, Cavanagh D, Roberts WS, LaPolla J. Upper Body Fat Distribution and Endometrial Cancer Risk. Oncology; 1992; Italy.

Kumar NB, Schapira DV, Lyman GH. Estimated Breast Cancer Risk Reduction with Weight Loss: Implications in Dietetic Practice. Annual Research Conference American Institute of Cancer Research; 1992.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk Within Families. 15th Annual Breast Cancer Symposium; 1992.

Schapira DV, Kumar NB, Clark RA, Yag C. Mammography Screening Credit Card and Compliance. International Conference on Prevention Cancer Symposium; 1992.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk Within Families. International Conference on Prevention Cancer Symposium; 1992.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk Within Families. International Congress on Hormones and Breast Cancer; 1992.

Kumar NB, Kritch KM, Bostow DE. Your Diet and Cancer: An Interactive Computer Tutorial. Association for Behavior Analysis; 1992.

Schapira DV, Kumar NB. Body Fat Distribution, Sex Hormones and Breast Cancer Risk Reduction. American Society of Clinical Oncology; 1992.

of 59


Schapira DV, Kumar NB, Clark R, Yag C. Mammography Screening Credit Card and Compliance. American Society of Clinical Oncology; 1992.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk Within Families. American Society of Clinical Oncology; 1992.

Schapira DV, Kumar NB, Lyman GH. Effects of Duration of Intervention and Locus of Control in Dietary Change. Yearbook of Family Practice - Mosby Yearbook; 1992.

Kumar NB, Kritch KM, Bostow DE. Your Diet and Cancer: An Interactive Computer Tutorial. Association for Behavior Analysis; 1992.

Kumar NB, Schapira DV, Lyman GH. Estimated Breast Cancer Risk Reduction with Weight Loss: Implications in Dietetic Practice. Annual American Institute of Cancer Research; 1992.

Kumar NB, Schapira DV, Lyman GH. Estimated Breast Cancer Risk Reduction with Weight Loss: Implications in Dietetic Practice. American Institute of Cancer Research Annual Conference; 1992; Washington, D.C., USA.

Kumar NB, Bostow DE, Schapira DV, Kritch KM. Efficacy of Interactive, Automated, Programmed Instruction in Nutrition Education. American Dietetic Association Annual Conference; 1993.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk Within Families. American Dietetic Association Annual Conference; 1993.

Kumar NB, Bostow DE, Schapira DV, Kritch KM. Efficacy of Interactive, Automated, Programmed-Instructions in Nutrition Education. American Dietetic Association Annual Conference; 1993.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk within Families. International Society of Preventive Oncology; 1993.

Schapira DV, Kumar NB, Clark RA, Yag C. Mammography Screening Credit Card and Compliance. 15th Annual Breast Cancer Symposium; 1993.

Schapira DV, Kumar NB, Lyman GH. Variation in Body Fat Distribution and Cancer Risk within Families. Clinical Digests; 1993.

Kumar NB, Aziz N, Schapira DV, Cox CE, Lyman GH. Weight at Age 30 and Breast Cancer Risk. American Institute of Cancer Research - Diet and Breast Cancer Annual Research Conference; 1993; Washington, D.C.

Lyman GH, Kumar NB, Lyman SH, Harris J. Breast Cancer Risk Associated with Cigarette Use in Women. Prevention; 1994.

of 59


Schapira DV, Wolff PA, Kumar NB, Anderson JB, Aziz NM, Lyman GH, Swanson M. The effect of weight loss on estimated breast cancer risk and sex hormone levels. American Cancer Society; 1994.

Kumar NB, Aziz N, Schapira DV, Cox C, Lyman GH. Weight at Age 30 and Breast Cancer Risk. American Society of Clinical Oncology; 1994.

Kumar NB. Anthropometry, Sex Hormones and Cancer Risk. 7th Annual Meeting of the New England Association of Cancer Research; 1995; Providence, RI, USA.

Kumar NB. Can Nutrients Inhibit the Cancer Process - Adjuvant Nutrition and Cancer Treatment? American College of Nutrition Cancer Treatment and Research Foundation; 1995 September; Washington, D.C., USA.

Kumar NB, Allen K, Cantor A, Cox C, Lyman GH, et al. Weight Gain Associated with Tamoxifen: Fact or Artifact?. 3rd Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology ; 1996; Nice, France.

Kumar NB, Lyman GH, Allen K, Cox CE, Schapira DV. Progressive Weight Gain in Women and Breast Cancer Risk: Opportunity for Breast Cancer Prevention. 3rd Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology; 1996; Nice, France.

Kumar NB, Cantor A, Allen K, Perkins J, Cox CE. Android Obesity at Diagnosis and Breast Cancer Survival. 4th Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology; 1998; Nice, France.

Kumar NB, Allen K, Cantor A, Shaw G, Cox CE. The Specific Role of Genistein in Estrogen Metabolism. 4th Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology-; 1998; Nice, France.

Kumar NB, Allen K, Cantor A, Shaw G, Cox CE. The Specific Role of Genistein in Estrogen Metabolism. 3rd International Symposium in the Role of Soy in Preventing and Treating Chronic Diseases; 1999 October; Washington, D.C., USA.

Kumar NB, Besterman-Dahan K, Allen K, Cantor A, Pow-Sang J, Seigne J. Specific Role of Genistein in Reducing Hormonal and Proliferative Risk Parameters that are implicated in the Promotion of Prostate Cancer. 5th Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology; 2000; Geneva, Switzerland.

Kumar NB, Allen K, Cantor A, Shaw G, Cox CE. The Specific Role of Genistein in Estrogen Metabolism: Final Results. 5th Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology; 2000; Geneva, Switzerland.

Kumar NB, Riccardi D, Allen K, Cantor A, Jacobsen P, Horton J, Minton S, Balducci L, Lyman GH. Weight Gain in Breast Cancer Patients on Chemotherapy: Exploring Hormonal, Body Composition and Behavioral Mechanisms: Preliminary

of 59


Results. 5th Annual Symposium on Predictive Oncology and Therapy, International Society for Preventive Oncology; 2000; Geneva, Switzerland.

Kumar NB, Besterman-Dahan K, Allen K, Cantor A, Pow-Sang J, Seigne J. Specific Role of Genistein in Reducing Hormonal and Proliferative Risk Parameters that are implicated in the Promotion of Prostate Cancer: Pilot Study Results. American Institute of Cancer Research Annual Research Conference; 2000 May; Washington, D.C., USA.

Kumar NB. Current Nutritional Health Challenges: Problems and Solutions. Diet & Cancer Prevention, Florida Society for Parenteral and Enteral Nutrition Annual Congress; 2000 September; Tampa, FL, USA.

Kumar NB. Alternative Nutritional Therapies in Cancer Treatment and Prevention. Nurse Practitioner Association for Continuing Education (NPACE) Conference; 2001 April; Orlando, FL, USA.

Kumar NB, Allen K, Cantor A, Shaw G, Cox CE. The Specific Role of Genistein in Estrogen Metabolism: Final Results. American Institute of Cancer Research Annual Meeting; 2001 May; Washington, D.C., USA.

Kumar NB, Riccardi D, Allen K, Cantor A, Jacobsen P. Horton J, Minton S, Balducci L, Lyman GH. Weight Gain in Breast Cancer Patients on Chemotherapy: Exploring Hormonal, Body Composition and Behavioral Mechanisms: Preliminary Results. American Institute of Cancer Research Annual Meeting; 2001 May; Washington, D.C., USA.

Kumar NB. The Specific Role of Isoflavones in Reducing Prostate Cancer Risk. International Society for Preventive Oncology Annual Symposium on Predictive Oncology and Therapy; 2004 February 07; Nice, France.

Kumar NB. Fatigue, Weight Gain, Lethargy and amenorrhea in breast cancer patients on chemotherapy: Is sub-climinal hypothyroidism the culprit? International Society for Preventive Oncology Annual Symposium on Predictive Oncology and Therapy; 2004 February 07; Nice, France.

Kumar NB. Herbals and Hormonal Implications. National Symposium on Pituitary Disorders; 2004 February 29; Clearwater, FL, USA.

Kumar NB. Sound Bytes: Bench to Bedside to Community and Beyond. Cancer, Culture & Literacy, Innovative Approaches for Advancing Effective Cancer Communications & Research; 2004 May 24; Clearwater Beach, FL, USA.

Kumar NB. Using teams to foster inter-institutional collaboration in developing educational software. WHISSL Project - Association of Schools of Allied Health Professions; 2004 October; Tampa, FL, USA.

Kumar NB. CCRIG Presentation. Florida A & M University Center for Minority Prostate Cancer Training and Research: A Collaborative Program between FAMU

of 59


and the H. Lee Moffitt Cancer Center and Research Institute, Inc. PC030462-Department of Defense; 2004 October 14; Tampa, FL, USA.

Kumar NB. Nutrients & Nutrient Derived Agents for Cancer Chemoprevention. Annual Meeting of the H. Lee Moffitt Cancer Center and Research Institute, Inc. CCOP Research Base; 2004 November 10; Tampa, FL, USA.

Kumar NB . Complementary/Integrative Nutritional Therapies for Cancer. H. Lee Moffitt Cancer Center and Research Institute, Inc., Nutritional Seminar Series; 2005 September 17; Tampa, FL, USA.

Kumar NB. Clinical Interventions of the Aging: Focus on Nutrition. 2nd International Symposium on Clinical Interventions in Aging, University of South Florida, College of Medicine; 2005 October 28; Tampa, FL, USA.

Kumar NB. Body Weight and the Cancer Survivor. American Institute for Cancer Research; 2005 November 10; Tampa, FL, USA.

Odedina FT, Kumar N. Increasing the Number of Minority Scientists to Eliminate Racial and Ethnic Disparities in Health: Lessons Learnt from Institutional and Community Collaborations. Office of Minority Health National Leadership Summit; 2006 January 09; Washington, D.C., USA.

Kumar NB. Disease-Specific Nutritional Approaches in Hypothalamic Pituitary Disorders. 4th National Symposium on Pituitary Disorders; 2006 October 05; Tampa, FL, USA.

Kumar NB. Metabolic Health: Nutritional Factors, Special Diets, Calorie Restriction & Aging. 2nd International Society for Applied Research in Aging (SARA), Symposium on Clinical Interventions in Aging; 2006 November; Las Vegas, NV, USA.

Kumar NB. The specific role of purified isoflavones in prostate cancer progression. American Association of Cancer Research (AACR) and JCA Joint International Conference - In the Forefront of Basic and Translational Cancer Research; 2007 January; Honolulu, HI, USA.

Reams R, Agrawal D, Kumar N, Odedina FT. Comparison of Prostate Cancer Gene Expression in African American and White American Males. 6th International Conference on the Burden to Cancer in Africa, African Organization for Research and Training in Cancer (AORTIC); 2007 October 24; Cape Town, South Africa.

Odedina FT, Kumar N, Jones L, Akinremi T. Prostate Cancer/Risk Factors in Nigerian Men: A Comparison of Indigenous and U.S. - Based Nigerian Men. 6th International Conference on the Burden of Cancer in Africa. African Organization for Research and Training in Cancer (AORTIC); 2007 October 24; Cape Town, South Africa.

Odedina FT, Kumar N, Akinremi T. An Exploratory Investigation of Prostate Cancer Knowledge, Cultural Beliefs and Values among Black Men of West African

of 59


Ancestry. The Science Center Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2007 November 27; Atlanta, GA, USA.

Kumar NB, Besterman-Dahan K, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Krischer JP. Lycopene in Prostate Cancer. American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium; 2008 February 14; San Francisco, CA, USA.

Kumar NB. Diets from Atkins to Zone. 58th American Society of Bariatric Physicians (ASBP). Annual Obesity and Associated Conditions Symposium; 2008 September 27; Tampa, FL, USA.

Kumar N. Lycopene and Prostate Cancer. European Organization for Research and Treatment of Cancer (EORTC) / National Cancer Institute (NCI) / American Society of Clinical Oncology (ASCO) Annual Meeting; 2009 October; Brussels, Belgium.

Kumar NB, Sebti S, Kazi A. Green Tea Catechins Mixture - (Polyphenon E) is an equally potent proteasome-inhibitor as purified FGCG. 2009 European Organization for Research and Treatment (EORTC) / National Cancer Institute (NCI) / American Society of Clinical Oncology (ASCO) Annual Meeting; 2009 October; Brussels, Belgium.

Kumar N. Omega-3 fatty acids in early phases of cancer cachexia. 6th Annual International Conference of the Society for Integrative Oncology (SIO); 2009 October; New York, NY, USA.

Kumar N. The Science of Patient Recruitment in a Phase II Chemoprevention Trial for Prostate Cancer. National Cancer Institute (NCI) / American Society of Clinical Oncology (ASCO) Cancer Trial Accrual Symposium - Science and Solutions; 2010 April; Bethesda, MD, USA.

Kumar NB. Diet and Other Lifestyle Factors in Hereditary Breast and Ovarian Cancers. 5th Annual International Meeting on Joining FORCEs Against Hereditary Cancer; 2010 June; Orlando, FL, USA.

Chornokur G, Lin H, Kumar NB. Comprehensive Population-Specific Marker Panel for Prostate Cancer Screening. 3rd American Association of Cancer Research Conference - The Science of Health Disparities; 2010 October; Miami, FL, USA.

Kumar N. Cytokines in the Sand: Diet and Cancer. The Link between Stress and Disease; 2010 November 04; Clearwater, FL, USA.

Kumar N. Diet & Other Lifestyle Factors in Hereditary Breast and Ovarian Cancers. 6th Annual International Meeting on Joining FORCEs Against Hereditary Cancer; 2011 June; Orlando, FL, USA.

Wilson D, Dapic V, Miladinovic B, Kumar A, Kumar NB, Connors S, Pow-Sang J, Rivers B. Developing a systematic review analyzing chemoprevention using natural and/or synthetic agents for prostate cancer. American Institute for Cancer

of 59


Research (AICR) Conference on Food, Nutrition, Physical Activity, and Cancer; 2011 November 03; Washington, D.C., USA.

Chornokur G, Han G, Tanner R, Lin J-Y, Gwede C, Kumar N, Pow-Sang J, Phelan C. The Risk Factors for Prostate Cancer in African American Men. American Association of Cancer Research (AACR) Annual Meeting; 2012 March 31; Chicago, IL, USA.

Kumar NB. Teleconference - National Management of Cancer Treatment Symptoms. Consortium of Academic Health Centers for Integrative Medicine, Oncology; 2012 April 27.

Kumar NB. Systematic Approach to Accelerating Botanical Drug Development for Prostate Cancer Chemoprevention and Treatment. 1st Florida Prostate Cancer Research Symposium; 2012 May 04; Orlando, FL, USA.

Connors S, Park J, Beg A, Kumar NB. Testing a Novel Cumulative Model of Green Tea Chemoprevention of Prostate Cancer: Preliminary Studies. 1st Florida Prostate Cancer Research Symposium; 2012 May 04; Orlando, FL, USA.

Chornokur G, Han G, Tanner R, Lin J-Y, Gwede C, Kumar N, Pow-Sang J, Phelan C. The Risk Factors for Prostate Cancer in African American Men. 1st Florida Prostate Cancer Research Symposium; 2012 May 04; Orlando, FL, USA.

Kumar NB. Systematic Approach to Accelerating Botanical Drug Development for Prostate Cancer Chemoprevention and Treatment. Indo-U.S. Workshop on Accelerating Botanical and Biologics Agent Development; 2012 May 27; Tampa, FL, USA.

Kumar NB. Proceeding Summary of the Workshop in Systematic Approach to Accelerating Botanical Drug Development for Prostate Cancer Chemoprevention and Treatment. National Cancer Institute (NCI) / American Society of Clinical Oncology (ASCO) Global Cancer Research; 2012 June 04; Chicago, IL, USA.

Kumar NB, Quinn GP, Smith T, Loew B, Van Dam J, Goodman N, Tseng BS. Perceptions of stage IV NSCLC patients and caregivers regarding severity of symptoms and willingness to participate in supportive care trials. Multinational Association of Supportive Care in Cancer (MASCC) / International Society of Oral Oncology (ISOO) International Symposium; 2012 June 28; New York, NY, USA.

Kumar NB. Green Tea Polyphenols in Prostate Cancer Prevention: From Bench to Bedside. 5th International Congress on Nutrition and Cancer; 2012 September; Elazig, Turkey.

Kumar NB. Round Table Discussion: Botanicals / Nutriceuticals in Symptom Management. 9th International Conference of the Society of Integrative Oncology; 2012 October; Albuquerque, NM, USA.

Chornokur G, Amankwah EK, Park JY, Phelan CM, Kumar NB. Polymorphisms in the metabolism related genes and obesity may explain prostate cancer disparity in

of 59


African American men. American Association of Cancer Research (AACR), The Science of Health Disparities Conference; 2012 October.

Chornokur G, Amankwah EK, Park JY, Phelan CM, Pow-Sang J, Kumar NB. Androgen Receptor CAG Repeat Length and Association with Prostate Cancer Risk in Obese and Non-Obese African American Men. 2nd Florida Prostate Cancer Research Symposium; 2013 March.

Kumar NB. Phytochemicals Review. The Halifax Project - A Broad-Spectrum Integrative Design for Cancer Prevention and Therapy; 2013 August 13; Halifax, Nova Scotia, Canada.

Kumar NB. Plant Based Substances and Omega 3 Fatty Acids for Cognitive Impairment in Breast Cancer Patients. Integrative Medicine Conference at Southwestern Regional Medical Center; 2013 November 01; Tulsa, OK, USA.

Chornokur G, Amankwah EK, Park JY, Phelan CM, Pow-Sang J, Kumar NB. Androgen Receptor CAG Repeat Length and Association with Prostate Cancer Risk in Obese and Non-Obese African American Men. 6th Annual American Association on Cancer Research (AACR) Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2013 December; Atlanta, GA, USA.

Kumar NB , Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Sebti S, Kazi A, Kang L, Quinn G, Smith T, Diaz K, Chornokur G, Crocker T, Schell MJ. Effect of Green Tea Catechins on Progression to Prostate Cancer after Diagnosis of High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation: A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial. 13th Annual American Association of Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research; 2014 September; New Orleans, LA, USA. Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Sebti S, Kazi A, Kang L, Quinn G, Smith T, Diaz K, Chornokur G, Crocker T, Schell MJ. Effect of Polyphenol E on Progression to Prostate Cancer after Diagnosis of High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation in African American Men: Preliminary finds of a Phase II randomized, double-blind, placebo-controlled Clinical Trial. 7th Annual American Association of Cancer Research (AACR) Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved conferences; 2014 November 09; San Antonio, TX, USA.

Kumar NB. Nutrition and Cancer prevention and survival. Miles for Moffitt-The First Step Club; 2015 February 26; Tampa, FL, USA.

Kumar NB. Nutritional Implications & Management of Pain. University of South Florida College of Medicine. Pain residents lecture; 2015 March 18; Tampa, FL, USA.

Kumar NB, Patel R, Pow-Sang J, Spiess PE, Salup R, Helal M, Williams CR, Yue B, Schell MJ. Effect of Green Tea Catechins in Modulation of Anthropometric

of 59


Variables. Proc of the STEM Research and Career Symposium, Emory University; 2015 March 26; Atlanta, GA, USA.

Kumar NB, Patel R, Pow-Sang J, Spiess PE, Salup R, Helal M, Williams CR, Yue B, Schell MJ. Effect of Green Tea Catechins in Modulation of Anthropometric Variables. 2015 undergraduate Research and Arts Colloquium. USF Morsani School of Medicine; 2015 April 9; Tampa, FL, USA.

Kumar NB. Proposal for a confirmatory trial of Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. ECOG-ACRIN (Eastern Cooperative Oncology Group (ECOG) and the American College of Radiology Imaging Network (ACRIN)) 2015 November 14; Orlando, FL, USA.

of 59

kumar - master cv 2016 feb

Documents